[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 23306
1. Pereira SB, Thiel Rdo R, Riccetto C, Silva JM, Pereira LC, Herrmann V, Palma P: [Validation of the International Consultation on Incontinence Questionnaire Overactive Bladder (ICIQ-OAB) for Portuguese]. Rev Bras Ginecol Obstet; 2010 Jun;32(6):273-8
MedlinePlus Health Information. consumer health - Urinary Incontinence.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Validation of the International Consultation on Incontinence Questionnaire Overactive Bladder (ICIQ-OAB) for Portuguese].
  • [Transliterated title] Validação do International Consultation on Incontinence Questionnaire Overactive Bladder (ICIQ-OAB) para a língua portuguesa.
  • PURPOSE: To translate, culturally adapt and validate the questionnaire "International Consultation on Incontinence Questionnaire Overactive Bladder" (ICIQ-OAB) for the Portuguese Language.
  • The final version of the ICIQ-OAB was applied together with the previously translated and tested version of the International Consultation on Incontinence Questionnaire - Short Form (ICIQ-SF) in 142 male and female patients with irritative urinary symptoms.
  • CONCLUSION: The culturally adapted version of the ICIQ-OAB translated into Brazilian Portuguese presented satisfactory reliability and survey validity and was considered valid for the evaluation of irritative urinary symptoms of Brazilian patients of both genders.
  • [MeSH-major] Surveys and Questionnaires. Urinary Bladder, Overactive / diagnosis. Urinary Incontinence / diagnosis

  • Genetic Alliance. consumer health - Incontinence.
  • MedlinePlus Health Information. consumer health - Overactive Bladder.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20945012.001).
  • [ISSN] 1806-9339
  • [Journal-full-title] Revista brasileira de ginecologia e obstetrícia : revista da Federação Brasileira das Sociedades de Ginecologia e Obstetrícia
  • [ISO-abbreviation] Rev Bras Ginecol Obstet
  • [Language] por
  • [Publication-type] English Abstract; Journal Article; Validation Studies
  • [Publication-country] Brazil
  •  go-up   go-down


2. Yagnik V, Chadha A, Chaudhari S, Patel K: Inflammatory myofibroblastic tumor of the urinary bladder. Urol Ann; 2010 May;2(2):78-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Inflammatory myofibroblastic tumor of the urinary bladder.
  • Inflammatory myofibroblastic tumor (IMT) of bladder is an uncommon benign tumor of bladder, which is of unknown neoplastic potential, characterized by spindle cell proliferation with characteristic fibroinflammatory and pseudosarcomatous appearance.
  • Essential criteria for the diagnosis of IMT are: spindle myoepithelial cell proliferation and lymphocytic infiltrate.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20882160.001).
  • [ISSN] 0974-7834
  • [Journal-full-title] Urology annals
  • [ISO-abbreviation] Urol Ann
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC2943686
  • [Keywords] NOTNLM ; Immunohistochemical staining / inflammatory myofibroblastic tumor / spindle myoepithelial cell proliferation
  •  go-up   go-down


3. Nerli RB, Kamat GV, Alur SS, Koura A, Prabha V, Amarkhed SS: Bladder exstrophy in adulthood. Indian J Urol; 2008 Apr;24(2):164-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bladder exstrophy in adulthood.
  • BACKGROUND: We report our experience with the treatment of classic exstrophy of the bladder in a small series of seven adult males.
  • There are very few documented cases of adults presenting with exstrophy of bladder in literature.
  • MATERIALS AND METHODS: Adult males presenting with classic exstrophy of the bladder and complete epispadias underwent detailed evaluation including psychological assessment and counseling.
  • Prior to 2002 all patients underwent cystectomy of the existing bladder plate, with creation of catheterizable modified Mainz pouch.
  • Since 2002 patients were assessed for bladder reconstruction with augmentation ileocystoplasty, bladder neck reconstruction, and abdominal wall closure.
  • RESULTS: Seven adult males with classic exstrophy of the bladder and complete epispadias who had not received any previous treatment presented to us during the period 1991-2006.
  • Five of these underwent cystectomy with continent pouch and the remaining two underwent bladder reconstruction.
  • CONCLUSIONS: Surgical correction in adults with exstrophy of the bladder greatly improves self-esteem, confidence, and social relationship.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Urol Clin North Am. 1983 Aug;10(3):473-81 [6623735.001]
  • [Cites] Urology. 1973 Jul;2(1):20-4 [4148867.001]
  • [Cites] J Urol. 1966 Mar;95(3):356-9 [5906001.001]
  • [Cites] BJU Int. 2004 May;93(7):1037-42 [15142160.001]
  • [Cites] Urology. 2001 May;57(5):906-10 [11337291.001]
  • [Cites] J Urol. 2005 May;173(5):1728-31 [15821570.001]
  • [Cites] J Urol. 1999 Jun;161(6):1934-41 [10332476.001]
  • [Cites] J Urol. 1997 Mar;157(3):947-8 [9072609.001]
  • [Cites] Int Urol Nephrol. 1996;28(6):747-50 [9089040.001]
  • [Cites] J Urol. 1996 Dec;156(6):2037-40 [8911384.001]
  • [Cites] J Urol (Paris). 1992;98(1):64-5 [1527404.001]
  • [Cites] Teratology. 1987 Oct;36(2):221-7 [3424208.001]
  • [Cites] Urol Int. 1987;42(1):74-6 [3590408.001]
  • (PMID = 19468391.001).
  • [ISSN] 0970-1591
  • [Journal-full-title] Indian journal of urology : IJU : journal of the Urological Society of India
  • [ISO-abbreviation] Indian J Urol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC2684262
  • [Keywords] NOTNLM ; Adult / augmentation ileocystoplasty / bladder reconstruction / epispadias / exstrophy bladder
  •  go-up   go-down


Advertisement
4. Mori Y, Maruyama T, Kondoh N, Nojima M, Yamamoto S, Shima H: [Orthotopic bladder substitution]. Hinyokika Kiyo; 2006 Jun;52(6):427-30

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Orthotopic bladder substitution].
  • Orthotopic bladder substitution is the most desired form of urinary diversion because the patient can restore normal voiding after cystectomy.
  • Each method of bladder substitution has merits and demerits.
  • We compared the Mainz method and the Studer method of orthotopic bladder substitution we performed on 8 and 11 patients, respectively since 1992.
  • The Studer orthotopic ileal bladder substitution has given better results with better voiding pattern and less complication rates.
  • We consider the Studer ileal bladder substitution as a good technique to restore normal voiding after cystectomy.
  • [MeSH-major] Ileum / surgery. Urinary Diversion / methods. Urinary Reservoirs, Continent

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16848355.001).
  • [ISSN] 0018-1994
  • [Journal-full-title] Hinyokika kiyo. Acta urologica Japonica
  • [ISO-abbreviation] Hinyokika Kiyo
  • [Language] jpn
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


5. Drake MJ: The integrative physiology of the bladder. Ann R Coll Surg Engl; 2007 Sep;89(6):580-5
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The integrative physiology of the bladder.
  • Normal bladder function is complex, resulting from the co-operative interaction of numerous regulatory cell types, of which the interstitial cells and the peripheral neurones are particularly interesting.
  • Collectively, these comprise the myovesical plexus, which appears to confer structural and functional characteristics on the bladder loosely akin to those of the gut.
  • These include functional modularity, which gives rise to the potential for localised and propagating peristalsis-like movements in the bladder wall according to the prevailing physiological conditions.
  • Localised modular activity during filling may contribute to normal generation of sensation and exaggerated modular activity may give rise to urinary urgency.
  • Enhanced co-ordination of modular activity occurs in various models of detrusor overactivity; it leads to surges of contraction over a large part of the bladder wall, generating phasic changes in intravesical pressure.
  • During voiding, the myovesical plexus sustains detrusor contraction at the behest of the brainstem, monitoring state of bladder fullness as it does so, as a guide to the required duration for which it has to keep up the effort.
  • Accordingly, the bladder wall itself may house structures which render the bladder the effector level in a hierarchy of lower urinary tract regulation.
  • Dysfunction in these vital regulatory structures is an underestimated factor in the pathophysiology of clinical bladder problems.
  • [MeSH-major] Urinary Bladder / physiology. Urinary Bladder Diseases / physiopathology

  • MedlinePlus Health Information. consumer health - Bladder Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Lab Invest. 2000 Oct;80(10):1491-9 [11045565.001]
  • [Cites] BJU Int. 2006 Sep;98(3):643-50 [16925766.001]
  • [Cites] J Urol. 2002 Aug;168(2):832-6 [12131376.001]
  • [Cites] Exp Physiol. 2003 Jan;88(1):19-30 [12525852.001]
  • [Cites] J Urol. 2003 Apr;169(4):1573-6 [12629418.001]
  • [Cites] BJU Int. 2003 May;91(7):702-10 [12699489.001]
  • [Cites] Exp Physiol. 2003 May;88(3):343-57 [12719759.001]
  • [Cites] J Urol. 2003 Jul;170(1):276-9 [12796704.001]
  • [Cites] J Physiol. 2004 Sep 1;559(Pt 2):567-81 [15235094.001]
  • [Cites] Neurourol Urodyn. 1993;12(5):463-71 [8252050.001]
  • [Cites] J Anat. 1997 Jan;190 ( Pt 1):125-34 [9034888.001]
  • [Cites] BJU Int. 2005 May;95(7):1002-5 [15839921.001]
  • [Cites] J Urol. 2006 Feb;175(2):771-6 [16407048.001]
  • [Cites] BJU Int. 2006 Mar;97(3):612-6 [16469036.001]
  • [Cites] BJU Int. 2006 Jun;97(6):1332-7 [16686734.001]
  • [Cites] Auton Autacoid Pharmacol. 2006 Jul;26(3):253-60 [16879490.001]
  • [Cites] Auton Autacoid Pharmacol. 2006 Jul;26(3):261-6 [16879491.001]
  • [Cites] Lancet. 2001 Aug 4;358(9279):401-3 [11502339.001]
  • (PMID = 18201471.001).
  • [ISSN] 1478-7083
  • [Journal-full-title] Annals of the Royal College of Surgeons of England
  • [ISO-abbreviation] Ann R Coll Surg Engl
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 19
  • [Other-IDs] NLM/ PMC2121225
  •  go-up   go-down


6. Kanematsu A, Yamamoto S, Ogawa O: Changing concepts of bladder regeneration. Int J Urol; 2007 Aug;14(8):673-8
MedlinePlus Health Information. consumer health - Bladder Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Changing concepts of bladder regeneration.
  • During the last decade, there has been a dramatic increase in studies aimed at regeneration of the urinary bladder.
  • Many studies employed animal-derived or synthetic materials as grafts for experimental bladder augmentation models, with or without additional measures to promote regeneration, such as autologous cell transplantation or growth factor loading.
  • One major problem in these studies is the lack of a clear distinction between native and regenerated bladder in total bladder function after augmentation.
  • In contrast, researchers have recently attempted to establish alternative regenerative strategies for treating bladder diseases, and have employed far more diverse approaches according to the various pathological conditions to be treated.
  • For total replacement of the bladder after cystectomy for invasive bladder cancer, urothelium-covered neobladder with non-urinary tract backbone remains a viable choice.
  • In addition, functional bladder diseases such as urinary incontinence, weak detrusor, or non-compliant fibrotic bladder have also been major targets for many leading research groups in this field.
  • Such altered research direction would inevitably lead to less surgically based basic biological research, and also would include a far wider spectrum of adult and pediatric bladder diseases, from overactive bladder to dysfunctional voiding.
  • [MeSH-major] Regeneration. Urinary Bladder / physiology. Urinary Bladder Diseases / physiopathology. Urinary Bladder Diseases / therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17681053.001).
  • [ISSN] 0919-8172
  • [Journal-full-title] International journal of urology : official journal of the Japanese Urological Association
  • [ISO-abbreviation] Int. J. Urol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Australia
  • [Number-of-references] 65
  •  go-up   go-down


7. Haferkamp A, Hohenfellner M: [Intravesical treatment of overactive bladder syndrome]. Urologe A; 2006 Oct;45(10):1283-8
Hazardous Substances Data Bank. OXYBUTYNIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Intravesical treatment of overactive bladder syndrome].
  • [Transliterated title] Intravesikale Therapie des Overactive-bladder-Syndroms.
  • Overactive bladder and urgency incontinence are common conditions generally treated with oral anticholinergic medication.
  • Botulinum toxin type A injections into the detrusor have been shown to increase bladder capacity and to decrease detrusor overactivity for 6 or more months.
  • Intravesical local anesthetics such as lidocaine and bupivacaine block the conduction of unmyelinated C fibers which results in an increase of functional bladder capacity.
  • Intravesical capsaicin and resiniferatoxin also affect the afferent C fiber innervation of the bladder, leading to a decrease in detrusor overactivity and also an increased bladder capacity.
  • In conclusion, intravesical therapies can provide an alternative treatment for the management of overactive bladder.
  • [MeSH-major] Administration, Intravesical. Cholinergic Antagonists / administration & dosage. Muscarinic Antagonists / administration & dosage. Urinary Bladder, Overactive / drug therapy. Urinary Incontinence / drug therapy

  • MedlinePlus Health Information. consumer health - Overactive Bladder.
  • MedlinePlus Health Information. consumer health - Urinary Incontinence.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Obstet Gynaecol. 1995 Nov;102(11):929-30 [8534633.001]
  • [Cites] Urology. 2000 May;55(5A Suppl):60-4; discussion 66 [10767456.001]
  • [Cites] J Urol. 1992 Aug;148(2 Pt 2):595-7 [1640530.001]
  • [Cites] J Urol. 1989 Jun;141(6):1350-2 [2724432.001]
  • [Cites] J Urol. 2002 Nov;168(5):1897-913 [12394674.001]
  • [Cites] J Urol. 2000 Sep;164(3 Pt 1):692-7 [10953127.001]
  • [Cites] Geburtshilfe Frauenheilkd. 1991 Jan;51(1):54-7 [2026301.001]
  • [Cites] Int Braz J Urol. 2004 Jan-Feb;30(1):53-8 [15707518.001]
  • [Cites] Lancet. 1992 May 16;339(8803):1239 [1349978.001]
  • [Cites] Curr Urol Rep. 2005 Nov;6(6):429-33 [16238916.001]
  • [Cites] Neurourol Urodyn. 2005;24(3):231-6 [15747344.001]
  • [Cites] J Urol. 2003 May;169(5):1892-5 [12686868.001]
  • [Cites] Arzneimittelforschung. 1998 May;48(5):486-91 [9638316.001]
  • [Cites] BJU Int. 2005 May;95(7):1023-7 [15839924.001]
  • [Cites] J Urol. 2005 Sep;174(3):984-9 [16094019.001]
  • [Cites] Am J Obstet Gynecol. 2005 May;192(5):1735-40 [15902187.001]
  • [Cites] Eur Urol. 2004 Jul;46(1):88-93; discussion 93-4 [15183552.001]
  • [Cites] J Urol. 2005 Sep;174(3):977-82; discussion 982-3 [16094018.001]
  • [Cites] J Med Assoc Thai. 2003 Sep;86(9):861-7 [14649971.001]
  • [Cites] Urology. 2005 Jul;66(1):82-7 [15992872.001]
  • [Cites] J Urol. 2000 Aug;164(2):340-3 [10893580.001]
  • [Cites] Urology. 2000 May;55(5A Suppl):33-46; discussion 50 [10767450.001]
  • [Cites] J Obstet Gynaecol. 2006 Feb;26(2):141-3 [16483973.001]
  • [Cites] Neurourol Urodyn. 1999;18(5):447-53 [10494116.001]
  • [Cites] Geburtshilfe Frauenheilkd. 1988 Aug;48(8):562-6 [3215450.001]
  • (PMID = 16972089.001).
  • [ISSN] 0340-2592
  • [Journal-full-title] Der Urologe. Ausg. A
  • [ISO-abbreviation] Urologe A
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Anesthetics, Local; 0 / Cholinergic Antagonists; 0 / Mandelic Acids; 0 / Muscarinic Antagonists; 0 / Neuromuscular Agents; EC 3.4.24.69 / Botulinum Toxins, Type A; K9P6MC7092 / oxybutynin
  • [Number-of-references] 26
  •  go-up   go-down


8. Schwalenberg T, Neuhaus J, Horn LC, Alexander H, Zimmermann G, Ho Thi P, Mallock T, Stolzenburg JU: [New insights in the differential diagnosis of bladder pain syndrome]. Aktuelle Urol; 2010 Mar;41(2):107-18
MedlinePlus Health Information. consumer health - Interstitial Cystitis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [New insights in the differential diagnosis of bladder pain syndrome].
  • [Transliterated title] Neue Erkenntnisse zur Differenzialdiagnostik des Bladder-Pain-Syndroms.
  • The diagnosis of bladder pain syndrome/interstitial cystitis (BPS/IC) is challenging, since pathogenetic mechanisms and the definition of clinical relevant parameters are still under lively discussion.
  • The criteria recently proposed by the European Society for the Study of Interstitial Cystitis (ESSIC) define a collective of patients based on the cardinal symptom of bladder pain which is heterogeneous, and therefore cannot receive standardised consistent therapy.
  • Thus an extended diagnosis based on molecular markers seems to be indicated to render individual pharmacotherapy possible, and to contribute to elucidation of BPS/IC pathogenesis.
  • For this purpose we feel the vital need for taking a bladder biopsy.
  • The diagnosis of BPS/IC should rely on 3 "columns":.
  • Since a significant contribution of the 3 functional units of the bladder to the pathophysiology is most evident, the examinations should ideally include urothelium, lamina propria, and detrusor musculature.
  • [MeSH-major] Cystitis, Interstitial / diagnosis
  • [MeSH-minor] Biopsy. Capillaries / pathology. Capillaries / physiopathology. Chorionic Gonadotropin, beta Subunit, Human / genetics. Cystoscopy. Diagnosis, Differential. Gene Expression / physiology. Humans. Mast Cells / pathology. Mast Cells / physiology. Mucous Membrane / pathology. Mucous Membrane / physiopathology. Nerve Fibers / pathology. Nerve Fibers / physiology. Practice Guidelines as Topic. Receptors, G-Protein-Coupled / genetics. Risk Factors. Urinary Bladder / pathology. Urinary Bladder / physiopathology. Urinary Bladder, Overactive / classification. Urinary Bladder, Overactive / pathology. Urinary Bladder, Overactive / physiopathology. Urothelium / pathology. Urothelium / physiopathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Georg Thieme Verlag Stuttgart New York.
  • (PMID = 20309783.001).
  • [ISSN] 1438-8820
  • [Journal-full-title] Aktuelle Urologie
  • [ISO-abbreviation] Aktuelle Urol
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Chorionic Gonadotropin, beta Subunit, Human; 0 / Receptors, G-Protein-Coupled
  • [Number-of-references] 52
  •  go-up   go-down


9. Bensalah K, Patard JJ: [Management of T1G3 tumours of the bladder]. Ann Urol (Paris); 2006 Apr;40(2):93-100
MedlinePlus Health Information. consumer health - Bladder Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Management of T1G3 tumours of the bladder].
  • [Transliterated title] Prise en charge des tumeurs de vessie T1G3 management of T1G3 tumours of the bladder.
  • T1G3 tumours are the most aggressive superficial tumours of the bladder, with a high risk of recurrence and progression.
  • Complete endoscopic resection of the tumour is the first diagnostic and therapeutic step in T1G3 management.
  • A second resection should be done at 1 month to avoid residual tumour and misdiagnosis of a muscle infiltrative cancer.
  • As a result of treatment by instillations of Calmette and Guérin bacillus following endoscopic resection, a 5-year survival rate of 80% has been reported, with 50 to 60% of bladder preservation.
  • BCG is the only conservative treatment that has proven effectiveness on both tumour recurrence and progression.
  • Radical cystectomy can be chosen as first line treatment in patients with particularly aggressive tumours.
  • [MeSH-major] Urinary Bladder Neoplasms / diagnosis. Urinary Bladder Neoplasms / therapy
  • [MeSH-minor] Adjuvants, Immunologic / therapeutic use. BCG Vaccine / therapeutic use. Humans. Neoplasm Staging

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16709007.001).
  • [ISSN] 0003-4401
  • [Journal-full-title] Annales d'urologie
  • [ISO-abbreviation] Ann Urol (Paris)
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Adjuvants, Immunologic; 0 / BCG Vaccine
  • [Number-of-references] 58
  •  go-up   go-down


10. Gonzalo Rodríguez V, Sanz Justo L, de Miguel Santamaría I, Martínez de Iturrate J, Fernández del Busto E: [The use of NMP22 Bladder-Chek for the diagnosis and follow-up bladder cancer]. Arch Esp Urol; 2008 Apr;61(3):377-84
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [The use of NMP22 Bladder-Chek for the diagnosis and follow-up bladder cancer].
  • [Transliterated title] Empleo del NMP22 Bladder-Chek en el diagnóstico y seguimiento del cáncer de vejiga.
  • OBJECTIVES: The goal of this work is to evaluate the usefulness of NMP22 BladderChek in the diagnosis and follow-up of bladder cancer, comparing it with cystoscopy and urine cytology.
  • METHODS: Group 1: 109 asymptomatic patients on follow up for bladder cancer underwent cystoscopy, cytology and NMP22 BladderChek.
  • RESULTS: Group 1: 9 patients had tumor relapse.
  • Group 2: 12 patients had bladder cancer.
  • CONCLUSIONS: The low sensitivity of NMP22 Bladder-Chek invalidates it as alternative method to cystoscopy in the follow-up of bladder cancer.
  • But it can be recommended for screening in patients without history of bladder cancer but with an increased risk (smokers, patients with dysuria and hematuria).
  • [MeSH-major] Biomarkers, Tumor / urine. Neoplasm Recurrence, Local / diagnosis. Nuclear Proteins / urine. Urinary Bladder Neoplasms / diagnosis
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Carcinoma, Transitional Cell / pathology. Cystoscopy. Cytodiagnosis. Female. Hematuria / etiology. Hematuria / urine. Humans. Male. Middle Aged. Neoplasm Staging. Predictive Value of Tests. Reagent Strips

  • Genetic Alliance. consumer health - Bladder cancer.
  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18581675.001).
  • [ISSN] 0004-0614
  • [Journal-full-title] Archivos españoles de urología
  • [ISO-abbreviation] Arch. Esp. Urol.
  • [Language] spa
  • [Publication-type] Comparative Study; English Abstract; Evaluation Studies; Journal Article
  • [Publication-country] Spain
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Nuclear Proteins; 0 / Reagent Strips; 0 / nuclear matrix protein 22
  •  go-up   go-down


11. Aguilera Tubet C, Gutiérrez Baños JL, Antolín Juárez F, Rebollo Rodrigo MH, Portillo Martín JA, Ruiz Izquierdo F, Ballestero Diego R, Martín García B: [Comparative study between cystoscopy, urinary cytology, NMP-22 and a new method, bladder chek, in the follow-up of superficial bladder cell carcinoma]. Actas Urol Esp; 2005 Mar;29(3):252-6
MedlinePlus Health Information. consumer health - Urine and Urination.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Comparative study between cystoscopy, urinary cytology, NMP-22 and a new method, bladder chek, in the follow-up of superficial bladder cell carcinoma].
  • [Transliterated title] Estudio comparativo entre cistoscopia, citología urinaria, NMP-22 y un nuevo método, bladder chek, en el seguimiento del cáncer vesical superficial.
  • OBJECTIVE: The goal of this work tries to evaluate the utility of the qualitative determination of NMP-22 in the evaluation of the superficial bladder carcinoma in asymptomatic patients, comparing it with its quantitative determination, the cytology and the cystoscopy.
  • MATERIALS AND METHODS: A simple of urine just voided was taken in 88 asymptomatic patient follow-up for superficial bladder cell carcinoma.
  • This dose was distributed in 3 parts, for performed cytology, for determination of NMP-22, and 4 drops of the third part are added to device bladder chek.
  • Later, we performed cystoscopy and transurethral resection in patients with a suspicion of bladder cancer.
  • RESULTS: 26 patients had tumor relapse and 62 patients were free of disease.
  • The sensitivity for the bladder chek was of 28%, 34.62% for NMP-22, 34.62% for cytology and 100% for cystoscopy.
  • The sensitivity by degree was 25 in G1, 28.57 in G2 and 50 in G3 for Bladder chek; 29.41, 42.86 and 50 for NMP-22; 23.53, 71.43 and 0 for cytology.
  • The sensitivity by stages was 27.7 in Ta-1 and 50 in T2 for Bladder chek; 34.78 and 50 for NMP-22; 39.13 and 0 for the cytology.
  • CONCLUSIONS: The low sensitivity of bladder chek invalidates it like alternative method to the cystoscopy in the follow-up of the superficial asymptomatic bladder cell carcinoma.
  • [MeSH-major] Carcinoma, Transitional Cell / diagnosis. Cystoscopy. Immunologic Tests. Nuclear Proteins / analysis. Urinary Bladder Neoplasms / diagnosis. Urine / cytology

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15945249.001).
  • [ISSN] 0210-4806
  • [Journal-full-title] Actas urologicas españolas
  • [ISO-abbreviation] Actas Urol Esp
  • [Language] spa
  • [Publication-type] Comparative Study; English Abstract; Journal Article
  • [Publication-country] Spain
  • [Chemical-registry-number] 0 / Nuclear Proteins; 0 / nuclear matrix protein 22
  •  go-up   go-down


12. Gaunez N, Larré S, Pirès C, Doré B, Wei J, Pfister C, Irani J: [French translation and linguistic validation of the questionnaire Bladder Cancer Index (BCI)]. Prog Urol; 2010 May;22(6):350-3
MedlinePlus Health Information. consumer health - Bladder Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [French translation and linguistic validation of the questionnaire Bladder Cancer Index (BCI)].
  • [Transliterated title] Traduction en langue française et validation linguistique de l'auto-questionnaire Bladder Cancer Index évaluant la qualité de vie dans les tumeurs de vessie.
  • OBJECTIVE: Translation and linguistic validation of the French version of Bladder Cancer Index (BCI).
  • MATERIAL AND METHODS: A double-back translation of the original Bladder Cancer Index was performed.
  • Finally, a pilot study followed by an interview was carried out among one woman and five men having bladder cancer.
  • The impact of various bladder cancer treatment on quality of life could hence be assessed and compared.
  • [MeSH-major] Surveys and Questionnaires. Urinary Bladder Neoplasms

  • Genetic Alliance. consumer health - Bladder cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2011 Elsevier Masson SAS. All rights reserved.
  • (PMID = 22541905.001).
  • [ISSN] 1166-7087
  • [Journal-full-title] Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie
  • [ISO-abbreviation] Prog. Urol.
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Validation Studies
  • [Publication-country] France
  •  go-up   go-down


13. Thiel DD, Williams BF, Krishna M, Leroy TJ, Igel TC: Robot-assisted laparoscopic excision of bladder wall leiomyoma. J Endourol; 2009 Apr;23(4):579-82; discussion 582
MedlinePlus Health Information. consumer health - Bladder Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Robot-assisted laparoscopic excision of bladder wall leiomyoma.
  • Leiomyoma is the most frequent nonepithelial benign tumor of the bladder, and only about 170 cases have been reported in the literature.
  • Most bladder wall leiomyomas are found incidentally and can be clinically followed if imaging and biopsy findings are consistent with the diagnosis.
  • Resection is usually performed for symptomatic or enlarging masses and is indicated if the diagnosis is in question.
  • We demonstrate imaging characteristics, port placement, operative technique, and surgical pathologic findings of the first reported case of robot-assisted laparoscopic resection of a bladder wall leiomyoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19335142.001).
  • [ISSN] 1557-900X
  • [Journal-full-title] Journal of endourology
  • [ISO-abbreviation] J. Endourol.
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


14. Wang CL, Tsai EM, Liu CM, Wu CH, Long CY: Incidental finding of a benign bladder tumor during the tension-free vaginal tape procedure. Gynecol Obstet Invest; 2007;63(1):28-30
MedlinePlus Health Information. consumer health - Pelvic Support Problems.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Incidental finding of a benign bladder tumor during the tension-free vaginal tape procedure.
  • However, concomitant resection of a bladder tumor during the TVT procedure is rare.
  • A bladder tumor located in the trigone was found incidentally during cystoscopy.
  • Concomitant resection of the bladder tumor was performed following the TVT procedure.
  • The surgical result of our patient suggests that concomitant resection of a benign intravesical pathology with TVT procedure is safe and effective.
  • [MeSH-major] Cystoscopy. Urinary Bladder Neoplasms / diagnosis. Urinary Bladder Neoplasms / surgery. Urinary Incontinence, Stress / surgery

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16864984.001).
  • [ISSN] 0378-7346
  • [Journal-full-title] Gynecologic and obstetric investigation
  • [ISO-abbreviation] Gynecol. Obstet. Invest.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Switzerland
  • [Number-of-references] 13
  •  go-up   go-down


15. Niu ZB, Yang Y, Hou Y, Chen H, Liu X, Wang CL: Lymphangioma of bladder. Urology; 2010 Oct;76(4):955-7
MedlinePlus Health Information. consumer health - Bladder Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lymphangioma of bladder.
  • Lymphangioma in the bladder is extremely rare.
  • Ultrasonography, computed tomogram, and retrograde urethrography showed a mass that was in the wall of the bladder.
  • The tumor was red and found to be bulging into the bladder on the right lateral wall of the bladder by cystoscopy.
  • A partial cystectomy was performed and histology revealed a lymphangioma of the bladder.
  • This case, to the authors' knowledge, represents the third reported case of lymphangioma of bladder.Lymphangiomas are benign, soft-tissue tumors of lymphatic origin.
  • They rarely affect the urinary system and a location in the bladder is extremely rare.
  • Only 2 cases of lymphangioma of the bladder have been reported worldwide since 1983.
  • The present report describes a patient with a lymphangioma of the bladder and the imaging characteristics of the lesion are reported, including imagings of sonography, computed tomography, retrograde urethrography, and histologic examination.
  • [MeSH-major] Lymphangioma / pathology. Urinary Bladder Neoplasms / pathology

  • Genetic Alliance. consumer health - Lymphangioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20494412.001).
  • [ISSN] 1527-9995
  • [Journal-full-title] Urology
  • [ISO-abbreviation] Urology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  •  go-up   go-down


16. Haylen BT: The empty bladder. Int Urogynecol J Pelvic Floor Dysfunct; 2007 Mar;18(3):237-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The empty bladder.
  • The empty (near-empty) bladder can have a volume ranging from 0 to 30 ml.
  • Its diagnosis is effectively and least invasively made by ultrasound (transvaginal superior).
  • It is a key marker of normal bladder function.
  • It is necessary for the accurate assessment of uterovaginal prolapse, as increasing bladder volume has been shown to reduce the extent of the prolapse.
  • Any negative effect of prolapse on voiding is reduced at high bladder volumes compared to voiding from low bladder volumes (due to the same reduction in the extent of the prolapse).
  • An empty bladder is optimal for bimanual pelvic examination and most transvaginal ultrasound examinations including that for uterine version.
  • The woman whose bladder is empty post-voiding is at a significantly lower risk of recurrent urinary tract infections.
  • The bladder that can't be emptied is a marker of bladder dysfunction, requiring a fuller investigation.
  • From a surgical point of view, the empty bladder improves access and reduces surgical risks with laparotomy, as well as both laparoscopic and vaginal surgery.
  • [MeSH-major] Urinary Bladder / physiology
  • [MeSH-minor] Female. Gynecologic Surgical Procedures. Humans. Recurrence. Urinary Tract Infections / physiopathology. Urination / physiology. Uterine Prolapse / physiopathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16791705.001).
  • [Journal-full-title] International urogynecology journal and pelvic floor dysfunction
  • [ISO-abbreviation] Int Urogynecol J Pelvic Floor Dysfunct
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


17. Juan Escudero JU, Ramos de Campos M, Ordoño Domínguez F, Fabuel Deltoro M, Serrano de la Cruz Torrijos F, Navalón Verdejo P, López Alcina E, Zaragoza Orts J: [Inguinoscrotal bladder hernias]. Arch Esp Urol; 2007 Apr;60(3):231-6
MedlinePlus Health Information. consumer health - Bladder Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Inguinoscrotal bladder hernias].
  • In the general population, only a small percentage of them involve the bladder.
  • Bladder wall weakness and bladder outlet obstruction are involved in its pathogenesis.
  • We present our experience in the diagnosis and treatment of this rare disease.
  • METHODS: A total of eight patients have been diagnosed of inguinoscrotal bladder hernia and treated in our center over the last 18 years.
  • In most cases, retrograde and voiding cystourethrograms, prostatic and bladder ultrasound, and uroflowmetry have been performed.
  • The treatment varied depending on the characteristics of the herniated bladder tissues and bladder capacity.
  • The treatment of bladder outlet obstruction varied depending on the etiology.
  • Resection of the herniated bladder tissue was carried out in four patients due to the quality of the tissue; bladder-pexy to the abdominis rectus muscles was performed in one patient; hernia repair with bladder reintroduction was the treatment in the other four cases.
  • Bladder outlet obstruction was treated in six cases.
  • Seven patients showed clinical improvement, showing normal bladder morphology on post operative cystogram.
  • CONCLUSIONS: Bladder hernia is a rare pathology often presenting in mid age males.
  • It should be suspected in every male with lower urinary tract obstructive symptoms and associated inguinal hernia.
  • The treatment of choice is that of the hernia and bladder outlet obstruction.
  • [MeSH-major] Genital Diseases, Male / diagnosis. Genital Diseases, Male / surgery. Hernia, Inguinal / diagnosis. Hernia, Inguinal / surgery. Scrotum. Urinary Bladder Diseases / diagnosis. Urinary Bladder Diseases / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17601297.001).
  • [ISSN] 0004-0614
  • [Journal-full-title] Archivos españoles de urología
  • [ISO-abbreviation] Arch. Esp. Urol.
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Spain
  • [Number-of-references] 16
  •  go-up   go-down


18. Charfi S, Moussa A, Njim L, Toffahi M, Hadhri R, Mahmoudi H, Zakhama A: [Micropapillary bladder carcinoma]. Prog Urol; 2006 Nov;16(5):607-9
MedlinePlus Health Information. consumer health - Bladder Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Micropapillary bladder carcinoma].
  • [Transliterated title] Carcinome micropapillaire de la vessie.
  • Micropapillary bladder carcinoma is a recently described, rare variant of urothelial carcinoma reputed for its poor prognosis.
  • The authors report the case of a 59-year-old man with invasive bladder tumour presenting with haematuria.
  • The authors discuss the clinicopathological and pathogenic features, treatment and clinical course of this tumour.
  • [MeSH-major] Carcinoma, Papillary / pathology. Urinary Bladder Neoplasms / pathology
  • [MeSH-minor] Hematuria / etiology. Humans. Male. Middle Aged. Neoplasm Invasiveness

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17175962.001).
  • [ISSN] 1166-7087
  • [Journal-full-title] Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie
  • [ISO-abbreviation] Prog. Urol.
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


19. Blah M, Nouira Y, Kallel Y, Hafsia GH, Horchani A: [Bladder herniation]. Ann Chir; 2005 Dec;130(10):633-5
MedlinePlus Health Information. consumer health - Bladder Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Bladder herniation].
  • Inguinal hernia of the bladder is uncommon.
  • The diagnosis is frequently done during surgery.
  • It can be evoked before surgery when the patient presents with irritative and obstructive lower urinary tract symptoms.
  • Retrograde urethrocystography or computerized tomography confirm the diagnosis.
  • We report a case of bilateral inguinal hernia involving the bladder at the right side in a 87 years old man who had a surgical history of transvesical adenomectomy of the prostate.
  • The diagnosis was done on the retrograde urethrocystography.
  • We performed bilateral herniorrhaphy with herniated bladder reduction.
  • [MeSH-major] Hernia, Inguinal / surgery. Urinary Bladder Diseases / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16043116.001).
  • [ISSN] 0003-3944
  • [Journal-full-title] Annales de chirurgie
  • [ISO-abbreviation] Ann Chir
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


20. Grima F, Golfier F, Raudrant D: [Clinicopathological correlation in bladder endometriosis]. Prog Urol; 2005 Jun;15(3):498-500
MedlinePlus Health Information. consumer health - Endometriosis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Clinicopathological correlation in bladder endometriosis].
  • Bladder endometriosis is a rare site of a disease with very polymorphic clinical signs.
  • The authors report the case of a 30-year-old woman operated for bladder endometriosis who presented with recent menstrual macroscopic haematuria with primary infertility and deep dyspareunia.
  • Histological examination demonstrated bladder endometriosis sparing the urothelium.
  • Comparison with our histological series of bladder endometriosis demonstrated polymorphic lesions ranging from integrity to complete loss of the bladder mucosa, with no correlation with clinical features.
  • [MeSH-major] Endometriosis / pathology. Urinary Bladder Diseases / pathology

  • Genetic Alliance. consumer health - Endometriosis.
  • MedlinePlus Health Information. consumer health - Bladder Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16097157.001).
  • [ISSN] 1166-7087
  • [Journal-full-title] Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie
  • [ISO-abbreviation] Prog. Urol.
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


21. Kavia R, Mumtaz F: Overactive bladder. J R Soc Promot Health; 2005 Jul;125(4):176-9
MedlinePlus Health Information. consumer health - Urinary Incontinence.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Overactive bladder.
  • Overactive bladder (OAB) is defined as urgency, with or without urge incontinence, usually with frequency and nocturia, in the absence of local pathological or hormonal factors.
  • ApproximateLy 70% of men with bladder outflow obstruction will have some symptoms of OAB.
  • The exact pathophysiology of OAB in bladder outflow obstruction is yet to be elucidated; evidence to date points to changes in both the efferent and afferent innervation and the detrusor.
  • More specific treatment options for OAB in bladder outflow obstruction include relief of the obstruction with surgical (e.g. transurethraL resection of prostate) or pharmaceutical (e.g. a blockers) methods.
  • [MeSH-major] Urinary Bladder Diseases / therapy. Urinary Incontinence / therapy

  • MedlinePlus Health Information. consumer health - Bladder Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16094929.001).
  • [ISSN] 1466-4240
  • [Journal-full-title] The journal of the Royal Society for the Promotion of Health
  • [ISO-abbreviation] J R Soc Promot Health
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Anti-Dyskinesia Agents; 0 / Muscarinic Antagonists; 0 / Muscle Relaxants, Central
  • [Number-of-references] 21
  •  go-up   go-down


22. Lebret T: [Infiltrating bladder tumours]. Rev Prat; 2007 Mar 31;57(6):630-40
MedlinePlus Health Information. consumer health - Bladder Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Infiltrating bladder tumours].
  • [Transliterated title] Tumeurs infiltrantes de la vessie.
  • Invasive bladder tumours are defined as carcinomas infiltrating the muscular fibbers of the bladder wall.
  • The assessment of tumour extension includes a clinical examination and an abdominopelvic computed tomography.
  • In patients with in situ bladder cancers, this treatment results in a five-year specific survival of 90 percent.
  • After bladder resection, several types of urinary diversion may be considered.
  • The efficiency of the neobladder should be monitored regularly to ensure a satisfactory urinary voiding as well as continence acquisition, which can be achieved through auto-rehabilitation.
  • [MeSH-major] Urinary Bladder Neoplasms / pathology. Urinary Bladder Neoplasms / surgery
  • [MeSH-minor] Cystectomy. Diagnostic Imaging. Humans. Neoplasm Invasiveness. Urinary Diversion

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17593787.001).
  • [ISSN] 0035-2640
  • [Journal-full-title] La Revue du praticien
  • [ISO-abbreviation] Rev Prat
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 10
  •  go-up   go-down


23. Hautmann RE: [Ileal bladder substitute]. Urologe A; 2008 Jan;47(1):33-4, 36-40

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Ileal bladder substitute].
  • The history of urinary diversion in general began in 1852 and started right away with continent diversion, i.e., ureterosigmoidostomy.
  • They replaced the bladder by an isoperistaltic ileal segment which was interposed between ureters and urethra in a female dog.
  • In 1951 Couvelaire reactivated this idea of an ileal bladder substitute.
  • Retrospectively many disappointing results of urinary diversion were often not caused by insufficient competence of the outlet mechanism, but because the intestinal reservoir maintained its peristaltic properties causing high pressure peaks.
  • Transsection of the circular intestinal musculature when performing bladder augmentation had already been published by Rutkowski in 1899, Tasker in 1953, and Giertz in 1957.
  • Reflux prevention in neobladders is even less important than in a normal bladder.
  • In these patients life is similar to that in individuals with a native lower urinary tract.
  • Until a better solution is devised orthotopic bladder reconstruction remains the best option for patients requiring cystectomy.
  • [MeSH-major] Urinary Diversion / history. Urinary Reservoirs, Continent / history

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Urol. 1996 Dec;78(6):840-6 [9014706.001]
  • [Cites] J Urol. 2006 Jan;175(1):185-9; discussion 189 [16406905.001]
  • [Cites] J Urol. 1987 Nov;138(5):1150-4 [3312639.001]
  • [Cites] Ann R Coll Surg Engl. 1970 Jun;46(6):320-37 [5420581.001]
  • [Cites] Br J Urol. 1953 Dec;25(4):349-57 [13115674.001]
  • [Cites] Urol Res. 1985;13(5):243-7 [4060368.001]
  • [Cites] J Urol. 1953 Oct;70(4):600-4 [13097637.001]
  • [Cites] Ann Surg. 1943 Jan;117(1):106-9 [17858159.001]
  • [Cites] Arch Surg. 1969 Aug;99(2):223-31 [5794896.001]
  • [Cites] Urol Clin North Am. 1986 May;13(2):321-31 [3515728.001]
  • [Cites] Urologe A. 1987 Mar;26(2):67-73 [3296394.001]
  • [Cites] Eur Urol. 1976;2(1):8-12 [971687.001]
  • [Cites] J Urol. 2005 Jan;173(1):144-7 [15592057.001]
  • [Cites] J Urol. 1957 Dec;78(6):683-720 [13482070.001]
  • [Cites] Acta Chir Scand. 1957 Oct 4;113(3):218-28 [13478409.001]
  • [Cites] Eur Urol. 1988;14 Suppl 1:36-40 [3181240.001]
  • [Cites] J Urol. 2005 Feb;173(2):482-4 [15643221.001]
  • [Cites] J Urol. 2003 Mar;169(3):834-42 [12576795.001]
  • [Cites] J Urol Medicale Chir. 1951;57(6):408-17 [14889638.001]
  • [Cites] J Urol. 1996 Dec;156(6):1913-7 [8911354.001]
  • [Cites] World J Urol. 2006 Aug;24(3):305-14 [16830152.001]
  • (PMID = 18210063.001).
  • [ISSN] 1433-0563
  • [Journal-full-title] Der Urologe. Ausg. A
  • [ISO-abbreviation] Urologe A
  • [Language] ger
  • [Publication-type] English Abstract; Historical Article; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


24. Hillard T: The postmenopausal bladder. Menopause Int; 2010 Jun;16(2):74-80
MedlinePlus Health Information. consumer health - Urinary Incontinence.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The postmenopausal bladder.
  • The bladder and its surrounding structures are rich in estrogen receptors and there are demonstrable physiological and anatomical changes that occur around and immediately after the menopause.
  • The prevalence of many bladder symptoms, such as frequency, urgency and incontinence, does seem to increase around the menopause, but there is continuing debate over whether these effects are due to ageing, menopause or a combination of the two.
  • The impact of the menopause varies with individual symptoms; stress urinary incontinence being associated more with estrogen deficiency than urge incontinence which seems to be more age-related.
  • Based on these effects, it could be anticipated that estrogen replacement would have a positive effect on bladder symptoms.
  • It seems that topical estrogens do have some positive effects, particularly on symptoms of urgency, frequency and urge incontinence, the prevention of urogenital atrophy and in the prevention of recurrent urinary tract infections.
  • The possible explanations for this apparent contradiction are explored, but based on current evidence, it would appear preferable to use vaginal estrogens rather than systemic as part of the management of menopause-related bladder problems.
  • [MeSH-major] Estrogen Replacement Therapy. Postmenopause / physiology. Urinary Bladder / physiopathology. Urinary Incontinence / etiology. Urinary Incontinence / physiopathology
  • [MeSH-minor] Administration, Intravaginal. Age Factors. Female. Humans. Receptors, Estrogen / physiology. Receptors, Progesterone / physiology. Urinary Tract Infections / prevention & control

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20729499.001).
  • [ISSN] 1754-0461
  • [Journal-full-title] Menopause international
  • [ISO-abbreviation] Menopause Int
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Receptors, Estrogen; 0 / Receptors, Progesterone
  •  go-up   go-down


25. Waine E, Stott M: Changing treatments for overactive bladder. Nurs Times; 2008 Oct 14-20;104(41):45-8
MedlinePlus Health Information. consumer health - Overactive Bladder.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Changing treatments for overactive bladder.
  • Overactive bladder is a common urological diagnosis which is often untreated as patients fail to seek help for this embarrassing problem.
  • Elizabeth Waine and Mark Stott summarise the symptoms and investigations for overactive bladder and provide an overview of the treatments available.
  • [MeSH-major] Urinary Bladder, Overactive / drug therapy. Urinary Incontinence, Urge / drug therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18979960.001).
  • [ISSN] 0954-7762
  • [Journal-full-title] Nursing times
  • [ISO-abbreviation] Nurs Times
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Muscarinic Antagonists; 0 / Neuromuscular Agents; 0 / Parasympatholytics; EC 3.4.24.69 / Botulinum Toxins, Type A
  • [Number-of-references] 20
  •  go-up   go-down


26. Zhang X, Gupta R, Nicastri AD: Bladder adenocarcinoma following gastrocystoplasty. J Pediatr Urol; 2010 Oct;6(5):525-7
MedlinePlus Health Information. consumer health - Bladder Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bladder adenocarcinoma following gastrocystoplasty.
  • Bladder augmentation with segments of small bowel (ileocystoplasty), large intestine (colocystoplasty) or stomach (gastrocystoplasty) has been used to treat patients with small or noncompliant bladders by increasing the capacity or compliance.
  • Carcinomas following gastrocystoplasty have been observed in the segments of stomach; however, to our knowledge, carcinoma arising in the residual native bladder has not been reported.
  • We report the first case of adenocarcinoma arising in the residual native bladder in association with intestinal metaplasia and dysplasia of bladder mucosa 17 years following gastrocystoplasty.
  • Intestinal metaplasia secondary to recurrent urinary infection, chronic inflammation, and some form of irritation may potentiate the development of native bladder adenocarcinoma.
  • Patients with gastrocystoplasty are at an increased risk for carcinoma in stomach segments and require close long-term follow up; however, the risk of carcinoma in native bladder is still unclear.
  • [MeSH-major] Adenocarcinoma / etiology. Urinary Bladder / surgery. Urinary Bladder Neoplasms / etiology. Urologic Surgical Procedures / adverse effects

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.
  • (PMID = 20392671.001).
  • [ISSN] 1873-4898
  • [Journal-full-title] Journal of pediatric urology
  • [ISO-abbreviation] J Pediatr Urol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


27. Carballo Alvarez M, Martínez Vilariño M, Llaga Rodríguez M: [Bladder cleansing]. Rev Enferm; 2008 Jan;31(1):27-30
MedlinePlus Health Information. consumer health - Bladder Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Bladder cleansing].
  • [Transliterated title] Lavado vesical.
  • Bladder cleansings are administered in order to maintain the permeability of a probe and/or to eliminate an obstruction, be it a clot, urinary sand or detritus, by means of an infusion of intravenous fluid using sterile procedures through a bladder catheter.
  • This is a technique frequently used with patients undergoing genital-urinary surgery; it is not recommended for routine usage due to its high risk of associated infection.
  • Bladder cleansing can be continuous by means of a permanent bladder cleansing method or intermittent by means of an open or closed system.
  • [MeSH-major] Therapeutic Irrigation. Urinary Bladder Diseases / therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18497003.001).
  • [ISSN] 0210-5020
  • [Journal-full-title] Revista de enfermería (Barcelona, Spain)
  • [ISO-abbreviation] Rev Enferm
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


28. Freeman RM, Adekanmi OA: Overactive bladder. Best Pract Res Clin Obstet Gynaecol; 2005 Dec;19(6):829-41
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Overactive bladder.
  • The overactive bladder is a common condition, which has significant effects on quality of life.
  • Management includes excluding pathology and implementing behavioural changes such as caffeine reduction, bladder and pelvic floor training, as well as antimuscarinic drug therapy.
  • [MeSH-major] Urinary Bladder Diseases / physiopathology
  • [MeSH-minor] Behavior Therapy / methods. Cholinergic Antagonists / therapeutic use. Electric Stimulation Therapy / methods. Estrogens / therapeutic use. Female. Humans. Muscle Contraction. Patient Compliance. Pelvic Floor / physiopathology. Prevalence. Quality of Life. Risk Factors. Terminology as Topic. Urinary Incontinence / etiology. Urinary Incontinence / surgery

  • MedlinePlus Health Information. consumer health - Bladder Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16176887.001).
  • [ISSN] 1521-6934
  • [Journal-full-title] Best practice & research. Clinical obstetrics & gynaecology
  • [ISO-abbreviation] Best Pract Res Clin Obstet Gynaecol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Cholinergic Antagonists; 0 / Estrogens
  • [Number-of-references] 83
  •  go-up   go-down


29. Nicola M, De Luca F: Bladder hernia. Arch Ital Urol Androl; 2006 Jun;78(2):77-8
MedlinePlus Health Information. consumer health - Bladder Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bladder hernia.
  • Bladder hernia is a rare condition, but crural herniation of the bladder into the scrotum is very rare.
  • A case of bladder hernia presenting with urological symptoms is described.
  • A 71-year-old man presented to the urological ward complaining for persistent frequency and nocturia associated with loss offorce and decrease of caliber of the urinary stream and the presence of a large mass of the right scrotum.
  • An IVP (intra venous pyelography) showed a large herniation of the bladder through the right inguinal canal into the scrotum.
  • The hernia sac, containing bowel and bladder, was dissectedfreefrom the spermatic cord and the testis and the hernia defect was repaired.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16929610.001).
  • [ISSN] 1124-3562
  • [Journal-full-title] Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica
  • [ISO-abbreviation] Arch Ital Urol Androl
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


30. Burks FN, Bui DT, Peters KM: Neuromodulation and the neurogenic bladder. Urol Clin North Am; 2010 Nov;37(4):559-65
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Neuromodulation and the neurogenic bladder.
  • Neurogenic bladder resulting from spinal cord injury and spina bifida has a profound impact on voiding function.
  • This article reviews the current literature with regards to electrical stimulation for neurogenic bladder and the clinical outcomes associated with sacral neuromodulation, pudendal neuromodulation, posterior tibial nerve stimulation, and the Finetech-Brindley posterior/anterior stimulator.
  • Neuromodulation, both electrical and physical, play an important role in the management of neurogenic bladder.
  • [MeSH-major] Electric Stimulation Therapy. Urinary Bladder, Neurogenic / therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20955907.001).
  • [ISSN] 1558-318X
  • [Journal-full-title] The Urologic clinics of North America
  • [ISO-abbreviation] Urol. Clin. North Am.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  •  go-up   go-down


31. Radosavljević R, Hadzi Djokić J, Aćimović M, Pejcić T, Tulić C, Dzamić Z: [Morphologic characteristics of the urothelial bladder tumors]. Acta Chir Iugosl; 2007;54(4):101-4
MedlinePlus Health Information. consumer health - Bladder Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Morphologic characteristics of the urothelial bladder tumors].
  • Cancer of the urinary bladder is the fourth most common cancer in men and the ninth in women.
  • Approximately 67,000 people (50,000 males and 17,000 females) develop bladder cancer each year in the United States, and 13,750 individuals (9,630 males and 4,120 females) are expected to die from it.
  • In the showing of the morphologic characteristics of the tumors, authors underlining the increasing of the incidence, pathogenesis, premalignant lesions and the risk factors of disease.
  • [MeSH-major] Carcinoma, Transitional Cell / pathology. Urinary Bladder Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18595239.001).
  • [ISSN] 0354-950X
  • [Journal-full-title] Acta chirurgica Iugoslavica
  • [ISO-abbreviation] Acta Chir Iugosl
  • [Language] hrv
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Serbia
  •  go-up   go-down


32. Henderson E, Drake M: Overactive bladder. Maturitas; 2010 Jul;66(3):257-62
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Overactive bladder.
  • Overactive bladder is a condition whose prevalence increases with ageing, and which can substantially impair quality of life.
  • It is defined by presence of urinary urgency, in the absence of other causes of similar problems.
  • The underlying mechanisms are incompletely understood, but may include increased excitability of smooth muscle, abnormal spread of excitation through the bladder wall, increased sensory nerve activity, and altered processing of information in the central nervous system.
  • Initial treatment comprises fluid advice and bladder training, followed by drug prescription.
  • Neuromodulatory techniques (sacral or tibial nerve stimulation) and reconstructive surgery (augmentation cystoplasty, detrusor myectomy or urinary diversion) can be offered in severe cases, but can have inadequate outcomes and significant implications.
  • [MeSH-major] Urinary Bladder / physiopathology. Urinary Bladder, Overactive / therapy. Urinary Incontinence, Urge / therapy

  • MedlinePlus Health Information. consumer health - Overactive Bladder.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Ireland Ltd. All rights reserved.
  • (PMID = 20399043.001).
  • [ISSN] 1873-4111
  • [Journal-full-title] Maturitas
  • [ISO-abbreviation] Maturitas
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Ireland
  • [Number-of-references] 54
  •  go-up   go-down


33. Yoshimura R, Adachi T, Funao K, Kobayakawa H, Matsuyama M, Tsuchida K, Takemoto Y, Nakatani T: Treatment of bladder tumors and benign prostatic hyperplasia with a new TUR system using physiological saline as perfusate. World J Surg; 2006 Mar;30(3):473-7
Hazardous Substances Data Bank. SODIUM CHLORIDE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Treatment of bladder tumors and benign prostatic hyperplasia with a new TUR system using physiological saline as perfusate.
  • We have treated both bladder tumor and benign prostatic hyperplasia cases with this new system.
  • When physiological saline is used as the perfusate, blood electrolyte levels are not greatly changed, even after extensive resection of the bladder wall; as a result, this new system is also cost effective because physiological saline is less expensive than non-electroconductive solutions and requires no counter-electrode.
  • [MeSH-major] Prostatic Hyperplasia / surgery. Sodium Chloride / administration & dosage. Transurethral Resection of Prostate / methods. Urinary Bladder Neoplasms / surgery


34. Pascual Mateo C, Nieto Gallego MA, Rodríguez García N, Luján Galán M, Berenguer Sánchez A: [Idiopathic local bladder amyloidosis]. Arch Esp Urol; 2005 Apr;58(3):253-5
MedlinePlus Health Information. consumer health - Bladder Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Idiopathic local bladder amyloidosis].
  • [Transliterated title] Amiloidosis vesical primaria localizada idiopática.
  • OBJECTIVE: To report one case of primary bladder amyloidosis.
  • RESULTS: Pathologic features were consistent with amyloidosis of the bladder wall.
  • CONCLUSIONS: Local idiopathic bladder amyloidosis is a very rare disease and the most common presenting symptom is painless hematuria.
  • It may be difficult to differentiate between this disease and a urothelial bladder neoplasia.
  • [MeSH-major] Amyloidosis / pathology. Urinary Bladder Diseases / pathology

  • Genetic Alliance. consumer health - Amyloidosis.
  • MedlinePlus Health Information. consumer health - Amyloidosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15906621.001).
  • [ISSN] 0004-0614
  • [Journal-full-title] Archivos españoles de urología
  • [ISO-abbreviation] Arch. Esp. Urol.
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


35. O'Hanlan KA: Cystosufflation to prevent bladder injury. J Minim Invasive Gynecol; 2009 Mar-Apr;16(2):195-7
Hazardous Substances Data Bank. Carbon dioxide .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cystosufflation to prevent bladder injury.
  • STUDY OBJECTIVE: This brief report will share information about the use and safety of inflating the bladder with carbon dioxide to delineate the margins during laparoscopic dissections near the bladder in patients who have scarring, adhesions, or challenging anatomy.
  • Indications included finding of adhesions from earlier cesarean section or massive myomas obscuring bladder margins, or planned anterior colpopexy or vaginal sacrocolpopexy.
  • INTERVENTIONS: Cystosufflation uniformly entailed the following: clamping of the bladder catheter with a Kelly clamp; connection of the laparoscopic carbon-dioxide insufflation tubing to the catheter; then under direct laparoscopic observation, release of the Kelly clamp with immediate bladder inflation revealing the cystic margins.
  • MEASUREMENTS AND MAIN RESULTS: Cystosufflation safely facilitated the dissection of the bladder off the anterior cervix and vagina, or off the anterior abdominal wall.
  • Distention of the bladder elevated and rounded up the bladder margins so that the muscularis could be clearly identified, preventing bladder injury in all patients.
  • [MeSH-major] Carbon Dioxide. Hysterectomy / methods. Insufflation / methods. Intraoperative Complications / prevention & control. Laparoscopy / methods. Urinary Bladder / injuries

  • MedlinePlus Health Information. consumer health - Hysterectomy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19138575.001).
  • [ISSN] 1553-4650
  • [Journal-full-title] Journal of minimally invasive gynecology
  • [ISO-abbreviation] J Minim Invasive Gynecol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 142M471B3J / Carbon Dioxide
  •  go-up   go-down


36. Boyle H, Fléchon A, Droz JP: [Uncommon bladder tumours]. Bull Cancer; 2010;97 Suppl Cancer de la vessie:51-7
MedlinePlus Health Information. consumer health - Bladder Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Uncommon bladder tumours].
  • [Transliterated title] Tumeurs rares de la vessie.
  • Bladder tumours are frequent with around 10,000 new cases each year in France.
  • These tumours are possibly secondary to alkylating drug metabolites or pelvic radiotherapy and they have often a poor prognostic outcome.
  • This is also the case of spindle cell carcinoma, an endocrine variant of rare bladder cancers.
  • Other tumours have a more locally invasive pattern, as have urachal adenocarcinomas, sarcomas.
  • The treatment is based on aggressive surgical exeresis of the tumour and surrounding structures.
  • [MeSH-major] Urinary Bladder Neoplasms

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20534390.001).
  • [ISSN] 1769-6917
  • [Journal-full-title] Bulletin du cancer
  • [ISO-abbreviation] Bull Cancer
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


37. Birder LA: TRPs in bladder diseases. Biochim Biophys Acta; 2007 Aug;1772(8):879-84
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] TRPs in bladder diseases.
  • This review attempts to provide an overview of the current knowledge of TRP proteins and their possible role in bladder function and disease.
  • Of those belonging to the group 1 subfamily, a number of TRPV, TRPM and TRPA proteins associated with osmoregulation, thermal, chemical and mechanical signaling mechanisms have been shown to be expressed within the lower urinary tract.
  • Though the biological role of many of these channels in urinary bladder function still remains elusive, TRPV1 is by far the best characterized and is thought to be involved in a number of bladder disorders [A.

  • MedlinePlus Health Information. consumer health - Bladder Diseases.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nature. 1997 Oct 23;389(6653):816-24 [9349813.001]
  • [Cites] Urology. 1997 Dec;50(6A Suppl):36-52; discussion 53-6 [9426749.001]
  • [Cites] Pharmacol Ther. 2005 May;106(2):179-208 [15866319.001]
  • [Cites] Neurosci Lett. 2005 Jun 10-17;381(1-2):42-6 [15882787.001]
  • [Cites] J Urol. 1999 Dec;162(6):1890-6 [10569531.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 May 23;97(11):6155-60 [10823958.001]
  • [Cites] Am J Physiol Renal Physiol. 2000 Jun;278(6):F867-74 [10836974.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):8134-9 [10859346.001]
  • [Cites] J Urol. 2000 Sep;164(3 Pt 1):676-9 [10953124.001]
  • [Cites] Nature. 2000 Dec 21-28;408(6815):985-90 [11140687.001]
  • [Cites] Regul Pept. 2001 Sep 15;101(1-3):1-18 [11495674.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13396-401 [11606761.001]
  • [Cites] Cell. 2002 Mar 8;108(5):705-15 [11893340.001]
  • [Cites] Neuroscience. 2002;109(4):787-98 [11927161.001]
  • [Cites] J Urol. 2002 Jul;168(1):293-7 [12050559.001]
  • [Cites] Science. 2002 Jun 14;296(5575):2046-9 [12016205.001]
  • [Cites] J Physiol. 2002 Aug 15;543(Pt 1):211-20 [12181293.001]
  • [Cites] Nat Neurosci. 2002 Sep;5(9):856-60 [12161756.001]
  • [Cites] Urology. 2003 Nov;62(5):909-13 [14624918.001]
  • [Cites] J Urol. 2004 Feb;171(2 Pt 1):938-43 [14713858.001]
  • [Cites] Urol Int. 2004;72(2):145-9 [14963356.001]
  • [Cites] J Biol Chem. 2004 Feb 20;279(8):7048-54 [14630912.001]
  • [Cites] BJU Int. 2004 Apr;93(6):770-6 [15049988.001]
  • [Cites] J Urol. 2004 Jun;171(6 Pt 1):2492-6 [15126883.001]
  • [Cites] Eur Urol. 2004 Jul;46(1):88-93; discussion 93-4 [15183552.001]
  • [Cites] J Urol. 2005 Sep;174(3):818 [16093961.001]
  • [Cites] J Urol. 2005 Sep;174(3):977-82; discussion 982-3 [16094018.001]
  • [Cites] J Physiol. 2005 Aug 15;567(Pt 1):53-8 [15961428.001]
  • [Cites] Eur J Neurosci. 2005 Aug;22(4):825-34 [16115206.001]
  • [Cites] Br J Urol. 1997 Dec;80(6):845-52 [9439395.001]
  • [Cites] J Urol. 1998 Jul;160(1):34-8 [9628600.001]
  • [Cites] Neurourol Urodyn. 1998;17(5):513-23 [9776014.001]
  • [Cites] World J Urol. 1999 Apr;17(2):126-30 [10367373.001]
  • [Cites] J Urol. 1999 Jul;162(1):3-11 [10379728.001]
  • [Cites] Am J Physiol. 1999 Sep;277(3 Pt 2):R786-94 [10484496.001]
  • [Cites] Urology. 2005 Feb;65(2):400-5 [15708075.001]
  • [Cites] J Cell Sci. 2005 Mar 1;118(Pt 5):917-28 [15713749.001]
  • [Cites] J Urol. 2005 May;173(5):1590-4 [15821499.001]
  • [Cites] Pflugers Arch. 2005 Oct;451(1):160-7 [15952037.001]
  • [Cites] Nat Clin Pract Urol. 2004 Dec;1(2):85-9 [16474520.001]
  • [Cites] Nat Clin Pract Urol. 2005 Oct;2(10):492-501 [16474623.001]
  • [Cites] Nat Clin Pract Urol. 2005 Nov;2(11):546-54 [16474598.001]
  • [Cites] J Neurosci. 2006 Apr 5;26(14):3864-74 [16597741.001]
  • [Cites] Endocr Relat Cancer. 2006 Mar;13(1):27-38 [16601277.001]
  • [Cites] J Urol. 2006 Jun;175(6):2341-4 [16697870.001]
  • [Cites] Biochem Pharmacol. 2006 Jun 28;72(1):104-14 [16725114.001]
  • [Cites] J Urol. 2006 Aug;176(2):797-801 [16813950.001]
  • [Cites] Naunyn Schmiedebergs Arch Pharmacol. 2006 Jul;373(4):287-99 [16721555.001]
  • [Cites] Mol Cell Neurosci. 2006 Aug;32(4):335-43 [16829128.001]
  • [Cites] Neurogastroenterol Motil. 2006 Aug;18(8):590-4 [16918723.001]
  • [Cites] Trends Mol Med. 2006 Nov;12(11):545-54 [16996800.001]
  • [Cites] Eur Urol. 2006 Dec;50(6):1299-305 [16697519.001]
  • [Cites] Nat Clin Pract Urol. 2007 Jan;4(1):46-54 [17211425.001]
  • [Cites] Cell Calcium. 2007 Mar;41(3):285-94 [16949669.001]
  • [Cites] Biochim Biophys Acta. 2007 Aug;1772(8):989-1003 [17321113.001]
  • [Cites] J Urol. 2004 Sep;172(3):1175-8 [15311065.001]
  • [Cites] Eur J Pharmacol. 2004 Oct 1;500(1-3):351-69 [15464045.001]
  • [Cites] J Urol. 1989 Jul;142(1):150-4 [2733095.001]
  • [Cites] J Auton Nerv Syst. 1990 Jul;30 Suppl:S71-7 [2212495.001]
  • [Cites] Ciba Found Symp. 1990;151:77-83; discussion 83-90 [2226067.001]
  • [Cites] Lancet. 1992 May 16;339(8803):1239 [1349978.001]
  • [Cites] Life Sci. 1993;52(20):PL221-6 [8483387.001]
  • [Cites] Brain Res. 1995 Apr 24;678(1-2):40-8 [7620897.001]
  • [Cites] J Urol. 1995 Nov;154(5):1825-9 [7563356.001]
  • [Cites] J Urol. 1997 Feb;157(2):585-9 [8996364.001]
  • [Cites] Am J Physiol. 1997 Apr;272(4 Pt 2):R1271-82 [9140030.001]
  • (PMID = 17560087.001).
  • [ISSN] 0006-3002
  • [Journal-full-title] Biochimica et biophysica acta
  • [ISO-abbreviation] Biochim. Biophys. Acta
  • [Language] ENG
  • [Grant] United States / NIDDK NIH HHS / DK / R01 DK57284; United States / NIDDK NIH HHS / DK / R01 DK54824; United States / NIDDK NIH HHS / DK / R01 DK057284-10; United States / NIDDK NIH HHS / DK / R37 DK054824-13; United States / NIDDK NIH HHS / DK / R01 DK057284; United States / NIDDK NIH HHS / DK / R37 DK054824-12; United States / NIDDK NIH HHS / DK / R01 DK057284-11; United States / NIDDK NIH HHS / DK / R37 DK054824; United States / NIDDK NIH HHS / DK / R56 DK057284; United States / NIDDK NIH HHS / DK / R01 DK054824
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Review
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Transient Receptor Potential Channels
  • [Number-of-references] 74
  • [Other-IDs] NLM/ NIHMS243025; NLM/ PMC3713460
  •  go-up   go-down


38. Spahn M, Bader P, Westermann D, Echtle D, Frohneberg D: Bladder carcinoma during pregnancy. Urol Int; 2005;74(2):153-9
MedlinePlus Health Information. consumer health - Tumors and Pregnancy.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bladder carcinoma during pregnancy.
  • INTRODUCTION: We report 3 cases of bladder cancer during pregnancy and give a review of the literature in an attempt to evaluate tumor at presentation, characteristics, maternal and fetal outcome.
  • MATERIALS AND METHODS: The case history of 3 pregnant women treated for bladder cancer in 2001 together with the results of a MEDLINE search from 1966 to 2003.
  • RESULTS: Out of 27 cases of nonbilharzial bladder carcinoma, 74% presented with transitional cell carcinoma.
  • Five patients had muscle-invasive tumors.
  • Only half of the tumors were identified by ultrasonography.
  • Although superficial bladder carcinoma was transurethrally resected alone, outcome and prognosis are good.
  • But the prognosis of locally advanced bladder carcinoma is poor.
  • CONCLUSION: Any doubtful genital bleeding during pregnancy without definite proof of vaginal/cervical origin should be investigated by both ultrasonography of the upper urinary tract and urethrocystoscopy.
  • Superficial bladder tumors can be most effectively treated by transurethral resection followed by cystoscopy, whereas the prognosis of muscle-invasive bladder carcinoma is poor and demands more radical treatment, depending on the stage of pregnancy.
  • [MeSH-major] Carcinoma, Transitional Cell. Pregnancy Complications, Neoplastic. Urinary Bladder Neoplasms

  • Genetic Alliance. consumer health - Pregnancy.
  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15756068.001).
  • [ISSN] 0042-1138
  • [Journal-full-title] Urologia internationalis
  • [ISO-abbreviation] Urol. Int.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Switzerland
  • [Number-of-references] 34
  •  go-up   go-down


39. Mann S, Johnson MP, Wilson RD: Fetal thoracic and bladder shunts. Semin Fetal Neonatal Med; 2010 Feb;15(1):28-33
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fetal thoracic and bladder shunts.
  • Congenital obstructive lesions involving the bladder and the lung can lead to serious complications for the newborn.
  • The in-utero placement of a diverting shunt in the fetal bladder or thoracic cavity can decrease the morbidity and mortality associated with these obstructive conditions.
  • This review focuses on the indications for prenatal evaluation, technique, and outcomes for those fetuses with a lower urinary tract obstruction, congenital pleural effusion or macrocystic congenital cystic adenomatoid malformation after placement of a vesicoamniotic or thoracoamniotic shunt.

  • MedlinePlus Health Information. consumer health - Fetal Health and Development.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2009. Published by Elsevier Ltd.
  • (PMID = 19596218.001).
  • [ISSN] 1878-0946
  • [Journal-full-title] Seminars in fetal & neonatal medicine
  • [ISO-abbreviation] Semin Fetal Neonatal Med
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Netherlands
  • [Number-of-references] 38
  •  go-up   go-down


40. Allen D, Glass J: Transvaginal contraception--avoid the bladder. Int J Clin Pract Suppl; 2005 Apr;(147):87-8
MedlinePlus Health Information. consumer health - Foreign Bodies.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Transvaginal contraception--avoid the bladder.
  • We report two cases of female contraceptive methods, resulting in urological presentation, with bladder foreign bodies.
  • History, mode of diagnosis and surgical extraction technique differed in both patients.
  • A second patient, with recurrent urinary tract infections, was found to have an intrauterine contraceptive device (IUCD) in her bladder on ultrasound.
  • Attempts to remove it endoscopically failed, and an, open procedure was required to free the IUCD from the bladder sidewall.
  • [MeSH-major] Foreign Bodies / etiology. Intrauterine Devices / adverse effects. Natural Family Planning Methods / adverse effects. Urinary Bladder
  • [MeSH-minor] Adult. Female. Humans. Thermometers. Urinary Tract Infections / etiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15875635.001).
  • [ISSN] 1368-504X
  • [Journal-full-title] International journal of clinical practice. Supplement
  • [ISO-abbreviation] Int J Clin Pract Suppl
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


41. Carr LK: Overactive bladder. Can J Urol; 2008 Aug;15 Suppl 1:32-6; discussion 36
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Overactive bladder.
  • Overactive bladder (OAB) is a common condition (prevalence 14%-18% of Canadians) and has a significant negative impact on quality of life.
  • OAB may be idiopathic or may occur with other common conditions such as bladder outlet obstruction, neurological disease, or stress incontinence.
  • [MeSH-major] Urinary Bladder, Overactive
  • [MeSH-minor] Behavior Therapy / methods. Canada / epidemiology. Diagnosis, Differential. Humans. Muscarinic Antagonists / therapeutic use. Neuromuscular Agents / therapeutic use. Prevalence. Prognosis. Urodynamics

  • MedlinePlus Health Information. consumer health - Overactive Bladder.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18700063.001).
  • [ISSN] 1195-9479
  • [Journal-full-title] The Canadian journal of urology
  • [ISO-abbreviation] Can J Urol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Canada
  • [Chemical-registry-number] 0 / Muscarinic Antagonists; 0 / Neuromuscular Agents
  • [Number-of-references] 21
  •  go-up   go-down


42. Katz DJ, Sengupta S, Snow RM: Isolated vasculitis of the bladder. Urology; 2005 Apr;65(4):797
MedlinePlus Health Information. consumer health - Vasculitis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Isolated vasculitis of the bladder.
  • We describe a case of isolated vasculitis involving the bladder that presented with severe irritative voiding and hematuria.
  • It is important to differentiate this rare pathologic entity from the much more frequent tumors of the bladder because the treatment is medical rather than surgical.
  • [MeSH-major] Urinary Bladder / blood supply. Urinary Bladder Diseases / diagnosis. Vasculitis / diagnosis

  • Genetic Alliance. consumer health - Vasculitis.
  • MedlinePlus Health Information. consumer health - Bladder Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15833535.001).
  • [ISSN] 1527-9995
  • [Journal-full-title] Urology
  • [ISO-abbreviation] Urology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


43. Griffiths D: Imaging bladder sensations. Neurourol Urodyn; 2007 Oct;26(6 Suppl):899-903
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Imaging bladder sensations.
  • Normal bladder sensations progress in a continuum of gradually increasing intensity and unpleasantness, from first sensation of bladder filling, through first desire to void, to strong desire to void.
  • The abnormal sensation of urgency is not part of this continuum and is one of the defining symptoms of the overactive bladder (OAB) syndrome.
  • We have imaged these cerebral responses in female volunteers, either with normal bladder control or with urge incontinence (poor control).
  • Normal bladder filling sensations are mapped mainly in the insula, shifting anteriorly as sensation becomes stronger and more unpleasant.
  • In subjects with poor bladder control, sensations and brain responses are different from normal.
  • Responses are relatively small at low bladder volumes (with mild sensation), but become exaggerated (with strong sensation) above a certain volume threshold, even when there is no actual detrusor overactivity.
  • Based on these results, it is unlikely that abnormal (OAB) responses to bladder filling can be accounted for simply by increased bladder afferent activity, that is, bladder hypersensitivity.
  • [MeSH-major] Brain / physiology. Magnetic Resonance Imaging. Sensation / physiology. Urinary Bladder / innervation. Urinary Incontinence, Urge / physiopathology

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2007 Wiley-Liss, Inc.
  • (PMID = 17654564.001).
  • [ISSN] 0733-2467
  • [Journal-full-title] Neurourology and urodynamics
  • [ISO-abbreviation] Neurourol. Urodyn.
  • [Language] eng
  • [Grant] United States / NIA NIH HHS / AG / R01-AG020629; United States / NIA NIH HHS / AG / R03-AG25166
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Number-of-references] 7
  •  go-up   go-down


44. Solifenacin and darifenacin for overactive bladder. Med Lett Drugs Ther; 2005 Mar 14;47(1204):23-4
MedlinePlus Health Information. consumer health - Urinary Incontinence.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Solifenacin and darifenacin for overactive bladder.
  • Darifenacin (Enablex) and solifenacin (VESIcare) are 2 new oral anticholinergics available for once-daily symptomatic treatment of overactive bladder.
  • Overactive bladder is a common condition in older patients.
  • In some experimental studies, the new drugs particularly target bladder receptors, but the clinical significance of these findings is unknown.
  • [MeSH-major] Benzofurans / therapeutic use. Pyrrolidines / therapeutic use. Quinuclidines / therapeutic use. Tetrahydroisoquinolines / therapeutic use. Urinary Incontinence / drug therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15767976.001).
  • [ISSN] 0025-732X
  • [Journal-full-title] The Medical letter on drugs and therapeutics
  • [ISO-abbreviation] Med Lett Drugs Ther
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Benzofurans; 0 / Pyrrolidines; 0 / Quinuclidines; 0 / Tetrahydroisoquinolines; APG9819VLM / darifenacin; KKA5DLD701 / Solifenacin Succinate
  •  go-up   go-down


45. Fumadó Ciutat L, Rodríguez Tolrà J, Pastor López S, Riera Canals L, Franco Miranda E: [Massive bladder hernia]. Arch Esp Urol; 2005 Dec;58(10):1078-80
MedlinePlus Health Information. consumer health - Bladder Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Massive bladder hernia].
  • [Transliterated title] Hernia vesical masiva.
  • OBJECTIVES: We report a case of a huge bladder hernia conditioning the migration of almost all the bladder into the scrotum.
  • METHODS AND RESULTS: 65-year-old male being studied for BPH who presents a scrotal tumor, which turned out to be a huge inguinal bladder hernia in scrotum, paraperitoneal, accompanied by an inguinal hernia.
  • The treatment consisted in bladder resection and repair of the inguinal hernia with a marlex mesh.
  • CONCLUSIONS: Bladder hernia is an uncommon pathology, and in most of the cases it is an incidental finding during the repair of an inguinal hernia.
  • The diagnosis is clinical, but comfirmation can be done by retrograde cystoghraphy, ultrasonography or CT The treatment is surgical, repairing the herniation or adding the resection of the bladder herniation.
  • [MeSH-major] Hernia, Inguinal / etiology. Urinary Bladder Diseases / complications

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16482863.001).
  • [ISSN] 0004-0614
  • [Journal-full-title] Archivos españoles de urología
  • [ISO-abbreviation] Arch. Esp. Urol.
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


46. Rioja Zuazu J, Toutziaris V, Laguna Pes MP, de Reijke TM, de la Rosette JJ: [Laser and bladder tumors]. Arch Esp Urol; 2008 Nov;61(9):994-1003
MedlinePlus Health Information. consumer health - Bladder Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Laser and bladder tumors].
  • Bladder cancer is one of the most frequents pathologies in urology.
  • We perform a review and try to assess the actual indications for its employment in the treatment of bladder cancer, as well as future applications.
  • [MeSH-major] Laser Therapy. Urinary Bladder Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19140580.001).
  • [ISSN] 0004-0614
  • [Journal-full-title] Archivos españoles de urología
  • [ISO-abbreviation] Arch. Esp. Urol.
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Spain
  • [Number-of-references] 44
  •  go-up   go-down


47. Karam JA, Kabbani W, Sagalowsky AI: Pseudosarcomatous fibromyxoid tumor of the bladder. Urol Oncol; 2008 May-Jun;26(3):291-4
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pseudosarcomatous fibromyxoid tumor of the bladder.
  • Pseudosarcomatous fibromyxoid tumors are uncommon lesions with uncertain pathogenesis.
  • Work-up revealed a bladder mass that was initially treated with transurethral resection that showed pseudosarcomatous fibromyxoid tumors.
  • Partial cystectomy is a viable option in the treatment of recurrent symptomatic pseudosarcomatous fibromyxoid tumors of the bladder, when performed selectively.
  • [MeSH-major] Fibroma / pathology. Sarcoma / pathology. Urinary Bladder Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18452822.001).
  • [ISSN] 1078-1439
  • [Journal-full-title] Urologic oncology
  • [ISO-abbreviation] Urol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


48. Lopes EJ, dos Santos TC, Martins V: [Schistosomiasis mansoni simulating bladder neoplasia]. Rev Soc Bras Med Trop; 2006 May-Jun;39(3):287-8
Hazardous Substances Data Bank. OXAMNIQUINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Schistosomiasis mansoni simulating bladder neoplasia].
  • [Transliterated title] Esquistossomose mansônica simulando neoplasia da bexiga.
  • Cytoscopy showed a protuberant tumor in the bladder anterior wall, suggestive of cancer.
  • Transurethral resection confirmed the diagnosis.
  • The case presented in this work emphasizes that not all the tumors of bladder with microscopic hematuria are bladder cancers.
  • [MeSH-major] Oxamniquine / therapeutic use. Schistosoma mansoni / isolation & purification. Schistosomiasis mansoni / diagnosis. Schistosomicides / therapeutic use. Urinary Bladder Diseases / parasitology
  • [MeSH-minor] Adult. Animals. Biopsy. Diagnosis, Differential. Humans. Male. Treatment Outcome. Urinary Bladder Neoplasms / diagnosis

  • Genetic Alliance. consumer health - Schistosomiasis.
  • MedlinePlus Health Information. consumer health - Bladder Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16906256.001).
  • [ISSN] 0037-8682
  • [Journal-full-title] Revista da Sociedade Brasileira de Medicina Tropical
  • [ISO-abbreviation] Rev. Soc. Bras. Med. Trop.
  • [Language] por
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Brazil
  • [Chemical-registry-number] 0 / Schistosomicides; 0O977R722D / Oxamniquine
  •  go-up   go-down


49. Foon R, Drake MJ: The overactive bladder. Ther Adv Urol; 2010 Aug;2(4):147-55

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The overactive bladder.
  • Urinary urgency and the associated symptoms which comprise overactive bladder are prevalent amongst the general population and adversely affect quality of life.
  • Disease management consists of a sequential series of options starting with behavioural and lifestyle techniques, pharmacological management (antimuscarinics) and, in severe cases, surgical treatment (urinary diversion, neuromodulation, augmentation cystoplasty and detrusor myectomy).
  • The hierarchy of the central nervous system control adds additional complexity to understanding the oflower urinary tract function.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Urol Int. 2004;72(2):145-9 [14963356.001]
  • [Cites] J Physiol. 2004 Sep 1;559(Pt 2):567-81 [15235094.001]
  • [Cites] J Urol. 2004 Aug;172(2):748-52 [15247775.001]
  • [Cites] Neurochem Int. 2004 Dec;45(7):987-93 [15337297.001]
  • [Cites] J Urol. 2005 Sep;174(3):977-82; discussion 982-3 [16094018.001]
  • [Cites] J Physiol. 2006 Jan 1;570(Pt 1):13-22 [16210349.001]
  • [Cites] BJU Int. 2006 Jan;97(1):29-32 [16336323.001]
  • [Cites] Br J Pharmacol. 2006 Feb;147 Suppl 2:S25-40 [16465182.001]
  • [Cites] BMC Urol. 2006;6:6 [16519806.001]
  • [Cites] Eur Urol. 2006 Nov;50(5):1050-7 [16753252.001]
  • [Cites] J Urol. 2006 Jul;176(1):177-85 [16753396.001]
  • [Cites] Eur Urol. 2006 Dec;50(6):1306-14; discussion 1314-5 [17049716.001]
  • [Cites] Eur Urol. 2007 May;51(5):1350-5; discussion 1355-6 [17070984.001]
  • [Cites] N Engl J Med. 2000 Mar 2;342(9):665 [10702067.001]
  • [Cites] Lab Invest. 2000 Oct;80(10):1491-9 [11045565.001]
  • [Cites] Am J Manag Care. 2000 Jul;6(11 Suppl):S599-606 [11183903.001]
  • [Cites] Lancet. 2001 Aug 4;358(9279):401-3 [11502339.001]
  • [Cites] Neurourol Urodyn. 2002;21(2):167-78 [11857671.001]
  • [Cites] BJU Int. 2000 May;85 Suppl 3:1-6; discussion 8-9 [11954191.001]
  • [Cites] Urology. 2004 Mar;63(3 Suppl 1):24-31 [15013649.001]
  • [Cites] Urol Clin North Am. 2005 Feb;32(1):113-5, viii [15698884.001]
  • [Cites] BJU Int. 2005 Aug;96(3):341-4 [16042727.001]
  • [Cites] J Urol. 2006 Jan;175(1):191-4; discussion 194-5 [16406907.001]
  • [Cites] BJU Int. 2006 Mar;97(3):547-50 [16469023.001]
  • [Cites] J Urol. 2006 Mar;175(3 Pt 1):999-1004; discussion 1004 [16469601.001]
  • [Cites] BJU Int. 2006 Sep;98(3):643-50 [16925766.001]
  • [Cites] Br J Urol. 1991 Nov;68(5):483-6 [1747722.001]
  • [Cites] BJU Int. 2007 Jun;99 Suppl 3:1-7 [17488366.001]
  • [Cites] Urology. 2008 May;71(5):839-43 [18342923.001]
  • [Cites] Br J Urol. 1978 Jun;50(4):243-5 [753469.001]
  • [Cites] Br J Urol. 1995 May;75(5):592-6 [7613795.001]
  • [Cites] Br J Urol. 1994 Jan;73(1):3-8 [8298896.001]
  • [Cites] Br J Urol. 1996 Mar;77(3):333-8 [8814833.001]
  • [Cites] J Urol. 1996 Nov;156(5):1744-7 [8863585.001]
  • [Cites] Scand J Urol Nephrol Suppl. 1996;179:47-53 [8908664.001]
  • [Cites] J Urol. 1997 Dec;158(6):2087-92 [9366318.001]
  • [Cites] Br J Urol. 1998 Jan;81(1):68-72 [9467479.001]
  • [Cites] J Urol. 2000 Feb;163(2):646-51 [10647702.001]
  • [Cites] Br J Pharmacol. 2002 Dec;137(7):1001-10 [12429572.001]
  • [Cites] World J Urol. 2003 May;20(6):327-36 [12811491.001]
  • [Cites] J Urol. 2003 Dec;170(6 Pt 1):2503-7 [14634460.001]
  • [Cites] Eur J Pharmacol. 2004 Jan 12;483(2-3):133-8 [14729100.001]
  • [Cites] Pharmacoeconomics. 2007;25(2):129-42 [17249855.001]
  • [Cites] J Pharmacol Exp Ther. 2007 May;321(2):642-7 [17293563.001]
  • [Cites] BJU Int. 2007 Aug;100(2):419-29 [17617145.001]
  • [Cites] J Pharmacol Exp Ther. 2007 Oct;323(1):202-9 [17626794.001]
  • [Cites] Cochrane Database Syst Rev. 2007;(3):CD005493 [17636801.001]
  • [Cites] Int J Urol. 2007 Jul;14(7):595-7 [17645600.001]
  • [Cites] Neurourol Urodyn. 2008;27(1):13-21 [17671973.001]
  • [Cites] Neurourol Urodyn. 2007 Oct;26(6 Suppl):914-9 [17763395.001]
  • [Cites] Neurourol Urodyn. 2007 Oct;26(6 Suppl):928-33 [17806124.001]
  • [Cites] J Urol. 2007 Nov;178(5):2029-34 [17869298.001]
  • [Cites] J Clin Invest. 2007 Nov;117(11):3453-62 [17948126.001]
  • [Cites] Eur Urol. 2008 Feb;53(2):391-9 [18031925.001]
  • [Cites] Naunyn Schmiedebergs Arch Pharmacol. 2008 Jun;377(4-6):449-62 [18060543.001]
  • [Cites] BJU Int. 2008 Mar;101(5):615-20 [18070178.001]
  • [Cites] Curr Med Res Opin. 2008 Feb;24(2):343-7 [18073008.001]
  • [Cites] Ann R Coll Surg Engl. 2007 Sep;89(6):580-5 [18201471.001]
  • [Cites] Am J Physiol Renal Physiol. 2008 Apr;294(4):F821-9 [18216148.001]
  • [Cites] Eur Urol. 2008 May;53(5):1029-37 [18243515.001]
  • [Cites] Naunyn Schmiedebergs Arch Pharmacol. 2008 Jun;377(4-6):473-81 [18311486.001]
  • [Cites] Eur Urol. 2008 Jun;53(6):1245-53 [18343564.001]
  • [Cites] Pflugers Arch. 2008 Oct;457(1):61-6 [18421472.001]
  • [Cites] BJU Int. 2008 Jun;101(11):1388-95 [18454794.001]
  • [Cites] Nat Clin Pract Urol. 2008 Jun;5(6):319-28 [18461049.001]
  • [Cites] Int J Urol. 2008 Aug;15(8):681-7 [18462357.001]
  • [Cites] Urology. 2008 Nov;72(5):1174-8 [18468662.001]
  • [Cites] J Urol. 2008 Jul;180(1):217-22 [18499184.001]
  • [Cites] Eur Urol. 2009 Jan;55(1):100-19 [18823697.001]
  • [Cites] Curr Urol Rep. 2008 Nov;9(6):445-51 [18947508.001]
  • [Cites] Clin Ther. 2008 Oct;30(10):1766-81 [19014833.001]
  • [Cites] Eur Urol. 2009 Jun;55(6):1440-8 [19054608.001]
  • [Cites] J Urol. 2009 Apr;181(4):1764-72 [19233423.001]
  • [Cites] BJU Int. 2009 Aug;104(3):352-60 [19281467.001]
  • [Cites] Neurourol Urodyn. 2010;29(1):49-55 [19412958.001]
  • [Cites] Neurourol Urodyn. 2010;29(1):82-7 [20025023.001]
  • [Cites] Neurourol Urodyn. 2010;29(1):119-27 [20025025.001]
  • [Cites] Br J Urol. 1995 Nov;76(5):551-7 [8535671.001]
  • [Cites] Cytokine. 1997 Sep;9(9):696-701 [9325019.001]
  • [Cites] Urology. 1997 Dec;50(6A Suppl):36-52; discussion 53-6 [9426749.001]
  • [Cites] Urology. 1997 Dec;50(6A Suppl):57-67; discussion 68-73 [9426752.001]
  • [Cites] World J Urol. 1998;16(4):268-73 [9775426.001]
  • [Cites] Drugs Aging. 2003;20(11):857-64 [12964892.001]
  • (PMID = 21789091.001).
  • [ISSN] 1756-2880
  • [Journal-full-title] Therapeutic advances in urology
  • [ISO-abbreviation] Ther Adv Urol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC3126078
  • [Keywords] NOTNLM ; detrusor overactivity / overactive bladder / urge incontinence / urgency
  •  go-up   go-down


50. Gargollo PC, Borer JG: Contemporary outcomes in bladder exstrophy. Curr Opin Urol; 2007 Jul;17(4):272-80
MedlinePlus Health Information. consumer health - Urinary Incontinence.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Contemporary outcomes in bladder exstrophy.
  • PURPOSE OF REVIEW: The patient with bladder exstrophy presents complex surgical and clinical management challenges to the pediatric urologist.
  • RECENT FINDINGS: Most of the early literature pertaining to bladder exstrophy has focused on surgical techniques and management.
  • Psychosexual development, sexual function and social adaptation have received as much attention as urinary continence status, bladder, and renal function.
  • SUMMARY: Despite the complex nature of bladder exstrophy, there are no well designed, prospective trials examining clinical outcomes in these patients.
  • Until better trials are planned, executed and published, much of what we know about patients with bladder exstrophy will be based on retrospective observations with significant biases.
  • [MeSH-major] Bladder Exstrophy / psychology. Bladder Exstrophy / surgery. Urinary Incontinence / psychology. Urinary Incontinence / surgery. Urologic Surgical Procedures / methods

  • Genetic Alliance. consumer health - Exstrophy of the Bladder.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17558272.001).
  • [ISSN] 0963-0643
  • [Journal-full-title] Current opinion in urology
  • [ISO-abbreviation] Curr Opin Urol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 63
  •  go-up   go-down


51. Sithasanan N, Kihne M, Naidu RR, Ramanujam TM: Twisted fate of bladder catheters. Med J Malaysia; 2006 Aug;61(3):369-70

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Twisted fate of bladder catheters.
  • Catheter knotting is a rare complication of bladder catheterisation.
  • We report a case of a vesical calculus formed over a broken and retained supra-pubic catheter which to the best of our knowledge has yet to be reported, along with three other cases of bladder catheter knotting.
  • [MeSH-major] Urinary Catheterization / instrumentation
  • [MeSH-minor] Adolescent. Child. Equipment Failure. Humans. Infant, Newborn. Male. Urinary Calculi / etiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17240594.001).
  • [ISSN] 0300-5283
  • [Journal-full-title] The Medical journal of Malaysia
  • [ISO-abbreviation] Med. J. Malaysia
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Malaysia
  •  go-up   go-down


52. Castillo O, Hoyos J, Vitagliano G, Arellano L: [Inverted papilloma of the bladder]. Arch Esp Urol; 2006 Sep;59(7):691-5
MedlinePlus Health Information. consumer health - Bladder Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Inverted papilloma of the bladder].
  • [Transliterated title] Papiloma invertido vesical.
  • OBJECTIVES: To report a series of patients with bladder inverted papilloma, pointing out the clinical features, presentations, treatment options and outcomes.
  • METHODS: We reviewed the medical charts of all patients with the diagnosis of bladder inverted papilloma treated by our group between July 1996 and June 2003.
  • RESULTS: 16 cases of inverted papilloma of the bladder were diagnosed in ten males and six females, with a mean age of 53.1 yr. (range 31-72).
  • In 14/16 patients the lesion was localized in the bladder trigone.
  • [MeSH-major] Papilloma, Inverted. Urinary Bladder Neoplasms

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17078392.001).
  • [ISSN] 0004-0614
  • [Journal-full-title] Archivos españoles de urología
  • [ISO-abbreviation] Arch. Esp. Urol.
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Spain
  • [Number-of-references] 12
  •  go-up   go-down


53. Nordling J: Sensory bladder disorders. Int J Clin Pract Suppl; 2006 Dec;(151):38-42
MedlinePlus Health Information. consumer health - Interstitial Cystitis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sensory bladder disorders.
  • Sensory bladder disorders include disorders involving abnormal sensations resulting from many diseases of the urinary bladder.
  • In a proportion of patients no cause can be found and if pain or pelvic pressure is a part of the symptomatology, they are labelled as having painful bladder syndrome (PBS).
  • In a subgroup of these patients abnormal findings can be demonstrated at cystoscopy and/or by histological examination of bladder biopsies.
  • This paper looks into the differential diagnosis, evaluation and treatment of patients with PBS.
  • [MeSH-major] Cystitis, Interstitial / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17169010.001).
  • [ISSN] 1368-504X
  • [Journal-full-title] International journal of clinical practice. Supplement
  • [ISO-abbreviation] Int J Clin Pract Suppl
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 43
  •  go-up   go-down


54. Yiee J, Wilcox D: Abnormalities of the fetal bladder. Semin Fetal Neonatal Med; 2008 Jun;13(3):164-70

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Abnormalities of the fetal bladder.
  • This review aims to outline the management of a fetus in whom a distended bladder or an absent bladder has been identified during prenatal fetal screening.
  • [MeSH-major] Fetus / abnormalities. Ureterocele / therapy. Urethra / abnormalities. Urinary Bladder / abnormalities
  • [MeSH-minor] Bladder Exstrophy. Cloaca / abnormalities. Female. Humans. Pregnancy. Prune Belly Syndrome / diagnosis. Syndrome. Ultrasonography, Prenatal

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18053783.001).
  • [ISSN] 1744-165X
  • [Journal-full-title] Seminars in fetal & neonatal medicine
  • [ISO-abbreviation] Semin Fetal Neonatal Med
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Netherlands
  • [Number-of-references] 46
  •  go-up   go-down


55. Spiess PE, Tuziak T, Tibbs RF, Bassett R, Tamboli P, Brown GA, Grossman HB, Ayala AG, Czerniak B: Pseudosarcomatous and sarcomatous proliferations of the bladder. Hum Pathol; 2007 May;38(5):753-61
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pseudosarcomatous and sarcomatous proliferations of the bladder.
  • Pseudosarcomatous fibromyxoid tumor (PFT), postoperative spindle cell nodule (PSN), sarcoma, and sarcomatoid carcinoma of the bladder are frequently difficult to distinguish histopathologically with significant differences in disease-related outcomes.
  • A retrospective review of our pathology registry over the last 25 years identified 7 PFT, 10 PSN, 18 primary bladder sarcomas, and 17 sarcomatoid carcinomas.
  • A previous history of urological instrumentation and bladder cancer was present in all patients with PSN but none of the patients with PFT.
  • Pseudosarcomatous fibromyxoid tumors were characterized by a tissue culture-like proliferation of myofibroblastic cells with focal atypia and overall cytoarchitectural features mimicking nodular fasciitis.
  • Pseudosarcomatous fibromyxoid tumor and PSN have unique clinical and pathologic features that allow their distinction from primary bladder sarcoma and sarcomatoid carcinoma.
  • [MeSH-major] Sarcoma / pathology. Urinary Bladder Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Carcinoma / pathology. Female. Fibroma / pathology. Humans. Male. Middle Aged. Neoplasm Metastasis. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17306332.001).
  • [ISSN] 0046-8177
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


56. Thwaini A, McLeod A, Nambirajan T: Laparoscopic bladder diverticulectomy. J Laparoendosc Adv Surg Tech A; 2008 Dec;18(6):849-51
MedlinePlus Health Information. consumer health - Bladder Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laparoscopic bladder diverticulectomy.
  • Acquired bladder diverticulae are herniations of the bladder mucosa through detrusor muscle.
  • Due to the ineffective emptying of the bladder diverticulum, urine accumulation may lead to urinary tract infection, stone disease, and lower urinary tract malignancy in the diverticulum.
  • We report a case of laparoscopic bladder diverticulectomy for transitional cell carcinoma in an acquired bladder diverticulum.
  • To our knowledge, this is the third case of laparoscopic diverticulectomy for a tumor.
  • [MeSH-major] Carcinoma, Transitional Cell / surgery. Diverticulum / surgery. Laparoscopy / methods. Urinary Bladder Diseases / surgery. Urinary Bladder Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19105670.001).
  • [ISSN] 1092-6429
  • [Journal-full-title] Journal of laparoendoscopic & advanced surgical techniques. Part A
  • [ISO-abbreviation] J Laparoendosc Adv Surg Tech A
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


57. Rigby D: Underactive bladder syndrome. Nurs Stand; 2005 May 11-17;19(35):57-64; quiz 66-7
MedlinePlus Health Information. consumer health - Bladder Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Underactive bladder syndrome.
  • Underactive bladder syndrome causes difficulty in voiding, resulting in incomplete bladder emptying.
  • [MeSH-major] Urinary Bladder Diseases / diagnosis. Urinary Bladder Diseases / therapy
  • [MeSH-minor] Clinical Protocols. Diagnosis, Differential. Female. Humans. Male. Quality of Life. Urinary Bladder / physiopathology. Urinary Catheterization / instrumentation. Urinary Catheterization / methods. Urinary Catheterization / nursing. Urine

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15915959.001).
  • [ISSN] 0029-6570
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 38
  •  go-up   go-down


58. Oliveira PA, Colaco A, De la Cruz P LF, Lopes C: Experimental bladder carcinogenesis-rodent models. Exp Oncol; 2006 Mar;28(1):2-11
MedlinePlus Health Information. consumer health - Bladder Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Experimental bladder carcinogenesis-rodent models.
  • Several rodent models of bladder cancer development have been established.
  • The aim of this review article is to provide a critical assessment of different animal models available for the study of bladder carcinogenesis, its chemoprevention and therapy.
  • Spontaneous bladder tumor models are extremely rare.
  • We describe chemical carcinogens most commonly used to induce bladder cancer, pellet implantation and urinary calculi, agents that promote bladder cancer, and irradiation.
  • We also evaluated other tools such as cell cultures, tumor implantation and transgenic models for bladder cancer, that have been developed to study the process.
  • The review considers how several imaging techniques can be applied to study rodent bladder carcinogenesis.
  • [MeSH-major] Neoplasms, Experimental. Urinary Bladder Neoplasms / pathology
  • [MeSH-minor] Animals. Animals, Genetically Modified. Carcinogens. Disease Models, Animal. Genetic Engineering. Humans. Neoplasm Transplantation / methods. Rodentia

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16614700.001).
  • [ISSN] 1812-9269
  • [Journal-full-title] Experimental oncology
  • [ISO-abbreviation] Exp. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] Ukraine
  • [Chemical-registry-number] 0 / Carcinogens
  • [Number-of-references] 99
  •  go-up   go-down


59. Tran H, Nguyen N, Nguyen T: Neonatal bladder rupture. Indian J Pediatr; 2009 Apr;76(4):427-9
MedlinePlus Health Information. consumer health - Bladder Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Neonatal bladder rupture.
  • Neonatal bladder rupture is rare as a complication of bladder obstruction due to abnormal anatomy or iatrogenic cause such as umbilical catheterization.
  • The present study describes the case of a 27-day old infant with ascites due to bladder perforation secondary to bladder wall necrosis as a result of severe urinary tract infection.
  • [MeSH-major] Urinary Bladder Diseases / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19205633.001).
  • [ISSN] 0973-7693
  • [Journal-full-title] Indian journal of pediatrics
  • [ISO-abbreviation] Indian J Pediatr
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


60. Wilkinson K: Supplementary prescribing for overactive bladder. Nurs Stand; 2005 Jan 19-25;19(19):38-42
MedlinePlus Health Information. consumer health - Urinary Incontinence.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Supplementary prescribing for overactive bladder.
  • Overactive bladder is a common condition that can be treated effectively in primary care by nurses.
  • Supplementary nurse prescribing enables nurses with the appropriate qualification to provide holistic programmes of care for individuals with an overactive bladder.
  • [MeSH-major] Community Health Nursing / organization & administration. Drug Prescriptions. Nurse Clinicians / organization & administration. Primary Health Care / organization & administration. Professional Autonomy. Urinary Incontinence / drug therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15700865.001).
  • [ISSN] 0029-6570
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 27
  •  go-up   go-down


61. Brand K, Littlejohn G, Kristjanson L, Wisniewski S, Hassard T: The fibromyalgia bladder index. Clin Rheumatol; 2007 Dec;26(12):2097-103
MedlinePlus Health Information. consumer health - Interstitial Cystitis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The fibromyalgia bladder index.
  • The aim of this study was to determine whether an existing outcome measure, the Interstitial Cystitis Symptom and Problem Index (ICSI/ICPI), is a valid, reliable, and clinically relevant instrument to assess the sensory urinary symptoms in women with fibromyalgia syndrome (FM).
  • Ninety women with American College of Rheumatology 90 FM and who had at least two sensory bladder symptoms participated in the study.
  • All underwent urological screening to exclude lower urinary tract pathology.
  • The eight items of the index configured differently and formed two subscales of a newly developed Fibromyalgia Bladder Index.
  • The two subscales of this index include the Bladder Urgency and Pain Subscale and the Bladder Frequency and Nocturia Subscale.
  • This index has high internal consistency reliability (Cronbach's alpha coefficient of 0.81), test-retest reliability showing intraclass correlation of 0.85, and high concurrent validity through correlations between the Fibromyalgia Bladder Index and the KHQ (0.735, p = 0.000) and the FIQ (0.433, p = 0.000).
  • This more specific configuration of the ICSI/ICPI better reflects FM bladder symptomatology.
  • The Fibromyalgia Bladder Index is a validated FM-specific instrument that captures information about the sensory bladder symptoms and their impact in this fibromyalgia population.
  • [MeSH-major] Cystitis, Interstitial / etiology. Fibromyalgia / complications. Urinary Bladder / physiopathology

  • Genetic Alliance. consumer health - Fibromyalgia.
  • MedlinePlus Health Information. consumer health - Fibromyalgia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17476564.001).
  • [ISSN] 0770-3198
  • [Journal-full-title] Clinical rheumatology
  • [ISO-abbreviation] Clin. Rheumatol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Belgium
  •  go-up   go-down


62. Neeli S, Prabha V, Alur S, Malur P: Penile metastasis from primay mucinous adenocarcinoma of bladder. Indian J Urol; 2007 Jul;23(3):314-6

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Penile metastasis from primay mucinous adenocarcinoma of bladder.
  • Primary adenocarcinoma of the urinary bladder is not common.
  • Though penile metastases from transitional cell carcinoma are reported, such metastases from adenocarcinoma of urinary bladder is unknown.
  • We report a 55-year-old male having penile metastasis from primary mucinous adenocarcinoma of bladder.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Urol. 1998 Aug;82(2):206-12 [9722755.001]
  • [Cites] Cancer. 1991 Apr 15;67(8):2165-72 [1706216.001]
  • [Cites] J Urol. 1990 Apr;143(4):671-8 [2179579.001]
  • [Cites] Br J Urol. 1971 Feb;43(1):4-15 [4926456.001]
  • [Cites] J Urol. 1964 May;91:538-48 [14154540.001]
  • [Cites] J Androl. 2003 Jul-Aug;24(4):499-500 [12826689.001]
  • [Cites] Urol Oncol. 2006 Jan-Feb;24(1):13-20 [16414487.001]
  • [Cites] Cancer. 1956 May-Jun;9(3):626-32 [13330017.001]
  • [Cites] Urology. 2003 Jul;62(1):145 [12837452.001]
  • (PMID = 19718338.001).
  • [ISSN] 0970-1591
  • [Journal-full-title] Indian journal of urology : IJU : journal of the Urological Society of India
  • [ISO-abbreviation] Indian J Urol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC2721614
  • [Keywords] NOTNLM ; Adenocarcinoma / penile metastasis / urinary bladder neoplasm
  •  go-up   go-down


63. Kajbafzadeh AM, Saeedi P, Sina AR, Payabvash S, Salmasi AH: Infantile bladder rupture during voiding cystourethrography. Int Braz J Urol; 2007 Jul-Aug;33(4):532-5; discussion 535
MedlinePlus Health Information. consumer health - Bladder Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Infantile bladder rupture during voiding cystourethrography.
  • Bladder rupture is rare during infancy and most of reported cases had urethral obstruction or neurogenic bladder.
  • We report two cases of infantile bladder rupture during voiding cystourethrography (VCUG).
  • Consideration of expected bladder volume for body weight, and close monitoring of bladder pressure and injection speed could prevent such complications.
  • [MeSH-major] Iatrogenic Disease. Urinary Bladder / injuries. Urinary Bladder Diseases / etiology. Urography / adverse effects

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17767759.001).
  • [ISSN] 1677-5538
  • [Journal-full-title] International braz j urol : official journal of the Brazilian Society of Urology
  • [ISO-abbreviation] Int Braz J Urol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Brazil
  • [Chemical-registry-number] 0 / Contrast Media
  •  go-up   go-down


64. Sakellaris G, Cervellione RM, Dickson AP: An unusual bladder/cloacal exstrophy with urachal exstrophy. Urol Int; 2008;81(1):113-5
Genetic Alliance. consumer health - Exstrophy of the Bladder.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An unusual bladder/cloacal exstrophy with urachal exstrophy.
  • The authors report a previously unpublished association of bladder exstrophy with cleft lip, exomphalos, Meckel's diverticulum imperforate anus, and a large urachal mass protruding below the umbilicus.
  • None of the theories formulated to explain the embryogenesis of bladder exstrophy can explain these findings.
  • The abnormality is within the bladder exstrophy/cloacal exstrophy spectrum.
  • [MeSH-major] Bladder Exstrophy / diagnosis. Cloaca / physiopathology. Urachus / physiopathology
  • [MeSH-minor] Abnormalities, Multiple. Anus, Imperforate / complications. Anus, Imperforate / diagnosis. Humans. Infant, Newborn. Male. Urinary Bladder / pathology

  • Genetic Alliance. consumer health - Cloacal Exstrophy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2008 S. Karger AG, Basel.
  • (PMID = 18645282.001).
  • [ISSN] 1423-0399
  • [Journal-full-title] Urologia internationalis
  • [ISO-abbreviation] Urol. Int.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


65. Horiuchi K, Shimizu H, Yoshida K, Nishimura T: New ultrasonic cystofiberscope for staging bladder tumors. J Endourol; 2005 Mar;19(2):130-2
MedlinePlus Health Information. consumer health - Bladder Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] New ultrasonic cystofiberscope for staging bladder tumors.
  • We report on a new ultrasonic cystofiberscope for staging bladder tumors.
  • The endoscope makes it possible to view endoscopic and ultrasound images of bladder tumors at any location, either alternately in full screen or simultaneously on the same monitor, with higher resolution.
  • The cystofiberscope is useful for assessing the depth of bladder tumor invasion accurately.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15798403.001).
  • [ISSN] 0892-7790
  • [Journal-full-title] Journal of endourology
  • [ISO-abbreviation] J. Endourol.
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


66. Chaurasia D, Agrawal R, Misra V, Bhargava A: Penoscrotal histoplasmosis following bladder carcinoma. Int J Urol; 2007 Jun;14(6):571-2
Hazardous Substances Data Bank. Itraconazole .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Penoscrotal histoplasmosis following bladder carcinoma.
  • The case is reported herein of a man with penoscrotal histoplasmosis following bladder carcinoma that had been treated with intravesical bacille Calmette-Guerin.
  • To the best of our knowledge, this is the first case of penoscrotal histoplasmosis following bladder carcinoma.
  • [MeSH-major] Histoplasmosis / diagnosis. Penis / microbiology. Scrotum / microbiology. Urinary Bladder Neoplasms / complications

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • MedlinePlus Health Information. consumer health - Histoplasmosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17593111.001).
  • [ISSN] 0919-8172
  • [Journal-full-title] International journal of urology : official journal of the Japanese Urological Association
  • [ISO-abbreviation] Int. J. Urol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Adjuvants, Immunologic; 0 / Antifungal Agents; 0 / BCG Vaccine; 304NUG5GF4 / Itraconazole
  •  go-up   go-down


67. Lau S, Zammit P, Bikhchandani J, Buchholz NP: The unbreakable bladder stone--Munchhausen's tale. Urol Int; 2006;77(3):284-5
MedlinePlus Health Information. consumer health - Foreign Bodies.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The unbreakable bladder stone--Munchhausen's tale.
  • A wide range of intra-vesical foreign bodies have been described in the literature.
  • We present an unusual case of fictitious bladder stones that proved unbreakable using all standard endourological techniques.
  • [MeSH-major] Foreign Bodies / diagnosis. Self Mutilation / diagnosis. Urinary Bladder / injuries. Urinary Bladder Calculi / diagnosis
  • [MeSH-minor] Adult. Cystoscopy. Diagnosis, Differential. Female. Humans. Urography

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2006 S. Karger AG, Basel.
  • (PMID = 17033221.001).
  • [ISSN] 0042-1138
  • [Journal-full-title] Urologia internationalis
  • [ISO-abbreviation] Urol. Int.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


68. Stanasel I, Mirzazadeh M, Smith JJ 3rd: Bladder tissue engineering. Urol Clin North Am; 2010 Nov;37(4):593-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bladder tissue engineering.
  • The bladder can lose the ability to store and empty effectively as a result of numerous conditions.
  • When conservative methods to maximize patient safety and quality of life fail, surgical reconstruction of the bladder is usually considered.
  • Multiple possibilities for sources of cells have been investigated, including stem cells and differentiated cells from organs other than the bladder; however, to date, autologous bladder cells remain the gold standard for culture and seeding.
  • [MeSH-major] Tissue Engineering. Urinary Bladder / surgery
  • [MeSH-minor] Humans. Regeneration. Stem Cells. Tissue Scaffolds. Urinary Bladder Diseases / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20955910.001).
  • [ISSN] 1558-318X
  • [Journal-full-title] The Urologic clinics of North America
  • [ISO-abbreviation] Urol. Clin. North Am.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  •  go-up   go-down


69. Irani J, Bernardini S, Davin JL, Guy L, Mazerolles C, Pfister C, Roupret M, Roy C, Rozet F, Saint F, Théodore C, Wallerand H, le comité de cancérologie de l'AFU: ["Superficial bladder cancers" do not exist anymore]. Prog Urol; 2008 Apr;18(4):204-5
MedlinePlus Health Information. consumer health - Bladder Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] ["Superficial bladder cancers" do not exist anymore].
  • [Transliterated title] Les << tumeurs superficielles de vessie >> n'existent plus.
  • "Superficial bladder tumours" term is progressively abandoned in the urological community because of its ambiguity leading possibly to harmful confusions.
  • The French Oncologic Society proposes to designate by non-infiltrating bladder neoplasm by the muscle Ta, T1 and Tis tumours.
  • [MeSH-major] Carcinoma, Transitional Cell / pathology. Urinary Bladder Neoplasms / pathology
  • [MeSH-minor] Cystectomy / methods. France. Humans. Neoplasm Staging. Risk Factors. Societies, Medical. Terminology as Topic. Time Factors. Treatment Outcome. Urology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18501298.001).
  • [ISSN] 1166-7087
  • [Journal-full-title] Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie
  • [ISO-abbreviation] Prog. Urol.
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


70. Yamaguchi O, Honda K, Nomiya M, Shishido K, Kakizaki H, Tanaka H, Yamanishi T, Homma Y, Takeda M, Araki I, Obara K, Nishizawa O, Igawa Y, Goto M, Yokoyama O, Seki N, Takei M, Yoshida M: Defining overactive bladder as hypersensitivity. Neurourol Urodyn; 2007 Oct;26(6 Suppl):904-7
MedlinePlus Health Information. consumer health - Urine and Urination.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Defining overactive bladder as hypersensitivity.
  • Overactive bladder (OAB), according to the International Continence Society (ICS) definition, is a symptom syndrome, with urgency as the cornerstone symptom.
  • Our patients deferred voiding until bladder sensation was relatively strong, suggesting that coping was not common among these patients.
  • At volumes exceeding 40% of the maximum bladder volume (MBV), urgency episodes occurred frequently and independently of the bladder volume, indicating that 40% of the MBV may be a threshold of bladder volume to induce urgency.
  • A linear relationship was observed between bladder volume and increasing bladder sensation.
  • However, compared with normal subjects, urge sensation increased markedly at any given bladder volume among patients with OAB in our study.
  • We therefore hypothesized that OAB may be more accurately defined as a hypersensitivity disorder rather than a syndrome characterized by urgency.
  • [MeSH-major] Adaptation, Psychological. Urinary Bladder / physiology. Urinary Bladder, Overactive / physiopathology. Urinary Bladder, Overactive / psychology. Urination / physiology

  • MedlinePlus Health Information. consumer health - Overactive Bladder.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2007 Wiley-Liss, Inc.
  • (PMID = 17663416.001).
  • [ISSN] 0733-2467
  • [Journal-full-title] Neurourology and urodynamics
  • [ISO-abbreviation] Neurourol. Urodyn.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 23
  •  go-up   go-down


71. Juszczak K, Wyczółkowski M, Thor PJ: [Pathophysiology of overactive bladder]. Przegl Lek; 2010;67(7):488-90
MedlinePlus Health Information. consumer health - Overactive Bladder.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Pathophysiology of overactive bladder].
  • Overactive bladder (OAB) is a complex of lower urinary tract symptoms (LUTS) frequently encountered in the clinical practice.
  • An understanding of the pathophysiology of OAB may facilitate effective treatment of this disorder.
  • [MeSH-major] Urinary Bladder, Overactive / physiopathology. Urinary Bladder, Overactive / therapy
  • [MeSH-minor] Animals. Humans. Urinary Bladder / innervation

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21387762.001).
  • [ISSN] 0033-2240
  • [Journal-full-title] Przegla̧d lekarski
  • [ISO-abbreviation] Prz. Lek.
  • [Language] pol
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Poland
  •  go-up   go-down


72. Zhang J, Gerst S, Lefkowitz RA, Bach A: Imaging of bladder cancer. Radiol Clin North Am; 2007 Jan;45(1):183-205
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Imaging of bladder cancer.
  • Bladder cancer is a heterogeneous and frequently multifocal disease with a variable clinical course.
  • The management of bladder cancer is therefore challenging and complicated.
  • CT and MR imaging have replaced the traditional excretory urography and are emerging as the imaging modalities of choice for work-up of patients who have bladder cancer.
  • Imaging provides essential diagnostic information for detection, staging, and post-treatment follow-up of bladder cancer.
  • [MeSH-major] Magnetic Resonance Imaging. Positron-Emission Tomography. Tomography, X-Ray Computed. Ultrasonography. Urinary Bladder Neoplasms / diagnosis. Urography
  • [MeSH-minor] Adult. Age Factors. Aged. Aged, 80 and over. Cystectomy. Cystoscopy. Cystostomy. Diagnosis, Differential. Female. Follow-Up Studies. Humans. Lymphatic Metastasis / diagnosis. Male. Middle Aged. Neoplasm Metastasis / diagnosis. Neoplasm Recurrence, Local / diagnosis. Neoplasm Staging. Prognosis. Time Factors. Treatment Outcome. Ultrasonography, Doppler. Urinary Bladder / pathology


73. Bhosle MJ, Wagner S, Ghantoji S, Balkrishnan R: Outcomes associated with pharmacotherapy in overactive bladder. Expert Rev Pharmacoecon Outcomes Res; 2005 Aug;5(4):447-56
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Outcomes associated with pharmacotherapy in overactive bladder.
  • Overactive bladder is one of the most prevalent medical conditions in the USA.
  • Prevalence rates of overactive bladder are higher in women and increase with advanced age.
  • Pharmacologic, as well as behavioral treatment therapies, are available for overactive bladder treatment with pharmacologic agents being the mainstay therapy.
  • The purpose of this review is to outline the recent developments in the treatment of overactive bladder.
  • This is an extensive review that provides important information on the outcomes associated with different pharmacotherapeutic agents used in overactive bladder.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19807262.001).
  • [ISSN] 1744-8379
  • [Journal-full-title] Expert review of pharmacoeconomics & outcomes research
  • [ISO-abbreviation] Expert Rev Pharmacoecon Outcomes Res
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


74. Elfiky AA, Rosenberg JE: Targeting angiogenesis in bladder cancer. Curr Oncol Rep; 2009 May;11(3):244-9
Hazardous Substances Data Bank. NICOTINAMIDE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Targeting angiogenesis in bladder cancer.
  • In most cases, death from bladder cancer results from metastatic disease.
  • Understanding the closely linked mechanisms of invasion, metastasis, and angiogenesis in bladder cancer has allowed development of new therapeutic strategies that may lead to improvements in patient survival.
  • Vascular endothelial growth factor levels appear to be prognostic for outcomes in advanced bladder cancer, and preclinical evaluation of angiogenesis inhibition demonstrates anticancer activity.
  • Antiangiogenic agents such as sunitinib, sorafenib, and bevacizumab are being tested in advanced bladder cancer.
  • This review highlights the key developments in antiangiogenic therapy as it relates to bladder cancer treatment.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Neovascularization, Pathologic / prevention & control. Urinary Bladder Neoplasms / drug therapy

  • Genetic Alliance. consumer health - Bladder cancer.
  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19336017.001).
  • [ISSN] 1534-6269
  • [Journal-full-title] Current oncology reports
  • [ISO-abbreviation] Curr Oncol Rep
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Angiogenesis Inhibitors; 0 / Antibodies; 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Humanized; 0 / Benzenesulfonates; 0 / IMC1C11; 0 / Phenylurea Compounds; 0 / Pyridines; 0 / VEGFA protein, human; 0 / Vascular Endothelial Growth Factor A; 25X51I8RD4 / Niacinamide; 2S9ZZM9Q9V / Bevacizumab; 9ZOQ3TZI87 / sorafenib; EC 2.7.10.1 / Receptors, Vascular Endothelial Growth Factor
  • [Number-of-references] 58
  •  go-up   go-down


75. Herr HW: Legacy of Edwin Beer: fulguration of papillary bladder tumors. J Urol; 2005 Apr;173(4):1087-9
MedlinePlus Health Information. consumer health - Bladder Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Legacy of Edwin Beer: fulguration of papillary bladder tumors.
  • PURPOSE: Edwin Beer introduced the first endoscopic treatment of papillary bladder tumors in 1910.
  • This historical review describes how his landmark discovery paved the way for office cystodiathermy to treat recurrent papillary tumors.
  • MATERIALS AND METHODS: The medical writings of Edwin Beer and all studies pertaining to the treatment of papillary bladder tumors from 1879 to the present were reviewed.
  • RESULTS: Edwin Beer discovered that papillary bladder tumors could be destroyed through the ordinary cystoscope with high frequency current by electro-coagulation.
  • This therapy revolutionized the treatment of bladder tumors.
  • CONCLUSIONS: The legacy of Edwin Beer is that office fulguration of recurrent papillary bladder tumors has now become a practical reality due to recent changes in the histological classification of papillary tumors, better definition of their biological behavior and improved endoscopic equipment.
  • [MeSH-major] Cystoscopes / history. Electrocoagulation / history. Urinary Bladder Neoplasms / history

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15758706.001).
  • [ISSN] 0022-5347
  • [Journal-full-title] The Journal of urology
  • [ISO-abbreviation] J. Urol.
  • [Language] eng
  • [Publication-type] Biography; Historical Article; Journal Article; Portraits
  • [Publication-country] United States
  • [Personal-name-as-subject] Beer E
  •  go-up   go-down


76. Corroppolo M, Zampieri N, Pietrobelli A, Giacomello L, Camoglio FS: Bladder exstrophy variants. Minerva Urol Nefrol; 2007 Mar;59(1):109-13
Genetic Alliance. consumer health - Exstrophy of the Bladder.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bladder exstrophy variants.
  • In the literature it is possible to find many case reports of bladder exstrophy variants, although a thorough classification with all possible associated malformations is not yet available.
  • The purpose of this study is to review the literature currently available and suggest a classification for bladder exstrophy variants.
  • [MeSH-major] Bladder Exstrophy / classification

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17431375.001).
  • [ISSN] 0393-2249
  • [Journal-full-title] Minerva urologica e nefrologica = The Italian journal of urology and nephrology
  • [ISO-abbreviation] Minerva Urol Nefrol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Italy
  • [Number-of-references] 36
  •  go-up   go-down


77. Guay DR: Darifenacin: another antimuscarinic for overactive bladder. Consult Pharm; 2005 May;20(5):424-31
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Darifenacin: another antimuscarinic for overactive bladder.
  • OBJECTIVE: To review darifenacin, a new anticholinergic for overactive bladder, approved in December 2004 by the U.S.
  • Darifenacin is extensively metabolized, with urinary excretion of parent compound being less than 10%.
  • No comparative data with marketed (for overactive bladder) anticholinergics are available.
  • On the basis of available data, darifenacin does not appear to be a substantial advance upon existing anticholinergics in the management of overactive bladder.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16548640.001).
  • [ISSN] 0888-5109
  • [Journal-full-title] The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists
  • [ISO-abbreviation] Consult Pharm
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


78. Ruffion A, Traxer O, Chartier-Kastler E: [Stones and neurogenic bladder]. Prog Urol; 2007 May;17(3):417-23

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Stones and neurogenic bladder].
  • [Transliterated title] Lithiase et vessie neurogène.
  • Stones of the upper and lower urinary tract are frequently observed in spinal cord injury patients.
  • In this article, the authors reviewed the literature to identify the most reliable tools for diagnosis and follow-up.
  • A review of recently published series demonstrated an excess risk of kidney and bladder stones in this population.
  • [MeSH-major] Urinary Bladder, Neurogenic / diagnosis. Urolithiasis / diagnosis
  • [MeSH-minor] Diagnosis, Differential. Humans. Risk Factors

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17622069.001).
  • [ISSN] 1166-7087
  • [Journal-full-title] Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie
  • [ISO-abbreviation] Prog. Urol.
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 64
  •  go-up   go-down


79. Dmochowski RR, Gomelsky A: Overactive bladder in males. Ther Adv Urol; 2009 Oct;1(4):209-21

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Overactive bladder in males.
  • The prevalence of overactive bladder (OAB) symptoms is considerable in both men and women and the impact on quality of life (QOL) is equally substantial.
  • Ironically, despite nearly equal prevalence, OAB symptoms in men are infrequently treated, and often with medical therapies aimed at bladder outlet obstruction (BOO).
  • In this review, we examine the pathophysiology of OAB and its evaluation in the context of benign prostatic hypertrophy and concomitant BOO.
  • We then consider the efficacy and safety of individual therapeutic options for lower urinary tract symptoms in men, focusing on the mainstays of medical therapy: α-adrenergic blockers, 5-α reductase inhibitors, and antimuscarinic agents.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Can J Physiol Pharmacol. 1983 Nov;61(11):1247-73 [6661682.001]
  • [Cites] Neurourol Urodyn. 1993;12(5):445-53 [7504554.001]
  • [Cites] Br J Urol. 1995 Sep;76(3):325-36 [7551841.001]
  • [Cites] Naunyn Schmiedebergs Arch Pharmacol. 2008 Jun;377(4-6):437-48 [18034230.001]
  • [Cites] BJU Int. 2008 Mar;101 Suppl 3:11-6 [18307680.001]
  • [Cites] Int J Clin Pract. 2008 May;62(5):688-94 [18355237.001]
  • [Cites] BJU Int. 2008 Jun;101(11):1388-95 [18454794.001]
  • [Cites] Urology. 2008 Nov;72(5):1061-7; discussion 1067 [18817961.001]
  • [Cites] Int J Urol. 2009 Mar;16(3):249-56 [19226359.001]
  • [Cites] J Urol. 2009 Apr;181(4):1779-87 [19233402.001]
  • [Cites] Sleep. 2009 Feb;32(2):271-5 [19238815.001]
  • [Cites] Am J Manag Care. 2009 Mar;15(4 Suppl):S98-S107 [19355804.001]
  • [Cites] J Urol. 2009 Jun;181(6):2591-8 [19375096.001]
  • [Cites] Br J Urol. 1994 Jul;74(1):50-6 [7519112.001]
  • [Cites] Int J Urol. 1997 Mar;4(2):111-25 [9179682.001]
  • [Cites] Urology. 1997 Dec;50(6A Suppl):57-67; discussion 68-73 [9426752.001]
  • [Cites] Pharmacol Ther. 1997 Aug;75(2):77-110 [9428000.001]
  • [Cites] J Physiol. 1976 Jul;259(1):223-37 [957214.001]
  • [Cites] BJU Int. 1999 Dec;84(9):953-60 [10571619.001]
  • [Cites] J Urol. 2000 Feb;163(2):535-9 [10647673.001]
  • [Cites] J Urol. 2000 Feb;163(2):646-51 [10647702.001]
  • [Cites] Pharmacol Rev. 1993 Sep;45(3):253-308 [8248281.001]
  • [Cites] J Urol. 1993 Nov;150(5 Pt 2):1650-6 [8411453.001]
  • [Cites] J Urol. 1993 Nov;150(5 Pt 2):1657-67 [8411454.001]
  • [Cites] Eur Urol. 1996;30(3):369-76 [8931972.001]
  • [Cites] J Urol. 1997 Mar;157(3):885-9 [9072592.001]
  • [Cites] J Urol. 1997 May;157(5):1802-13 [9112529.001]
  • [Cites] J Urol. 1997 May;157(5):1814-22 [9112530.001]
  • [Cites] J Urol. 1999 Feb;161(2):680-5 [9915482.001]
  • [Cites] Br J Pharmacol. 1999 Feb;126(3):819-25 [10188996.001]
  • [Cites] J Urol. 2000 Apr;163(4):1349-56 [10737542.001]
  • [Cites] J Am Geriatr Soc. 2000 Apr;48(4):370-4 [10798461.001]
  • [Cites] BJU Int. 2001 Jun;87(9):760-6 [11412210.001]
  • [Cites] Lancet. 2001 Aug 4;358(9279):401-3 [11502339.001]
  • [Cites] Am J Clin Nutr. 2002 Apr;75(4):689-97 [11916755.001]
  • [Cites] World J Urol. 2002 Sep;20(4):250-4 [12215856.001]
  • [Cites] Urology. 2003 Jan;61(1):37-49 [12559262.001]
  • [Cites] Am J Physiol Regul Integr Comp Physiol. 2003 May;284(5):R1241-8 [12676745.001]
  • [Cites] J Urol. 2003 Jun;169(6):2253-6 [12771763.001]
  • [Cites] J Urol. 1992 Nov;148(5):1549-57; discussion 1564 [1279218.001]
  • [Cites] BJU Int. 2003 Aug;92(3):257-61 [12887479.001]
  • [Cites] Urology. 2003 Nov;62(5 Suppl 2):3-10 [14662401.001]
  • [Cites] N Engl J Med. 2003 Dec 18;349(25):2387-98 [14681504.001]
  • [Cites] N Engl J Med. 2004 Feb 19;350(8):786-99 [14973214.001]
  • [Cites] Urology. 2004 Mar;63(3):461-5 [15028438.001]
  • [Cites] BJU Int. 2004 Oct;94(6):817-20 [15476515.001]
  • [Cites] Clin Ther. 2004 Nov;26(11):1701-13 [15639685.001]
  • [Cites] BJU Int. 2005 Sep;96 Suppl 1:37-42 [16083453.001]
  • [Cites] J Urol. 2005 Oct;174(4 Pt 1):1334-8 [16145414.001]
  • [Cites] J Urol. 2005 Dec;174(6):2273-5. discussion 2275-6 [16280803.001]
  • [Cites] Br J Pharmacol. 2006 Feb;147 Suppl 2:S25-40 [16465182.001]
  • [Cites] J Urol. 2006 Mar;175(3 Pt 1):999-1004; discussion 1004 [16469601.001]
  • [Cites] Eur Urol. 2006 Apr;49(4):651-8 [16530611.001]
  • [Cites] BJU Int. 2006 Apr;97(4):747-51, discussion 751 [16536766.001]
  • [Cites] Pharmazie. 2006 Mar;61(3):175-8 [16599254.001]
  • [Cites] Eur J Clin Pharmacol. 2006 May;62(5):347-54 [16602019.001]
  • [Cites] BJU Int. 2006 May;97(5):1003-6 [16643482.001]
  • [Cites] BJU Int. 2006 May;97(5):1017-23 [16643483.001]
  • [Cites] Prostate Suppl. 1990;3:9-26 [1689174.001]
  • [Cites] Eur Urol. 2006 Dec;50(6):1306-14; discussion 1314-5 [17049716.001]
  • [Cites] JAMA. 2006 Nov 15;296(19):2319-28 [17105794.001]
  • [Cites] Rev Urol. 2006;8 Suppl 4:S10-7 [17215996.001]
  • [Cites] Curr Med Res Opin. 2007 Jan;23(1):65-76 [17257467.001]
  • [Cites] Am J Clin Nutr. 2007 Feb;85(2):523-9 [17284753.001]
  • [Cites] Urol Int. 2007;78(2):97-105 [17293646.001]
  • [Cites] Chin Med J (Engl). 2007 Mar 5;120(5):370-4 [17376305.001]
  • [Cites] Int J Clin Pract. 2007 Sep;61(9):1535-46 [17627768.001]
  • [Cites] J Pharmacol Exp Ther. 2000 Jun;293(3):939-45 [10869395.001]
  • [Cites] BJU Int. 2001 May;87(7):617-22 [11350400.001]
  • [Cites] Urology. 2001 Jun;57(6 Suppl 1):111 [11378079.001]
  • [Cites] J Urol. 2001 Dec;166(6):2221-5 [11696739.001]
  • [Cites] J Urol. 2002 Feb;167(2 Pt 1):586-90 [11792923.001]
  • [Cites] J Auton Pharmacol. 2001 Oct-Dec;21(5-6):219-29 [12123466.001]
  • [Cites] J Urol. 2003 Jul;170(1):145-8 [12796667.001]
  • [Cites] World J Urol. 2003 May;20(6):327-36 [12811491.001]
  • [Cites] Lancet Neurol. 2004 Jan;3(1):46-53 [14693111.001]
  • [Cites] BJU Int. 2004 Apr;93(6):745-50 [15049984.001]
  • [Cites] Eur Urol. 2004 Dec;46(6):799-805 [15548450.001]
  • [Cites] J Urol. 2005 Apr;173(4):1302-8 [15758786.001]
  • [Cites] BJU Int. 2005 Sep;96(4):559-65 [16104910.001]
  • [Cites] Eur Urol. 2006 Jan;49(1):8-10 [16310934.001]
  • [Cites] Lancet. 1991 Jun 15;337(8755):1457-61 [1710750.001]
  • [Cites] Cell Tissue Res. 1990 Oct;262(1):67-79 [2257617.001]
  • [Cites] Acta Physiol Scand. 1974 Mar;90(3):565-77 [4830420.001]
  • [Cites] Br J Urol. 1970 Dec;42(6):714-23 [5491923.001]
  • (PMID = 21789068.001).
  • [ISSN] 1756-2880
  • [Journal-full-title] Therapeutic advances in urology
  • [ISO-abbreviation] Ther Adv Urol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC3126063
  • [Keywords] NOTNLM ; anticholinergic / benign prostatic hypertrophy / overactive bladder
  •  go-up   go-down


80. Oottamasathien S, Williams K, Franco OE, Thomas JC, Saba K, Bhowmick NA, Staack A, Demarco RT, Brock JW 3rd, Hayward SW, Pope JC 4th: Bladder tissue formation from cultured bladder urothelium. Dev Dyn; 2006 Oct;235(10):2795-801
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bladder tissue formation from cultured bladder urothelium.
  • Studies have reported the successful generation of primary cultures of rodent bladder urothelium, but none have reported their use to recapitulate bladder tissue with tissue recombination.
  • We propose that primary cultured bladder urothelium, when recombined with inductive embryonic bladder mesenchyme, will form bladder tissue in a recombination model.
  • Sheets of bladder urothelium were re-suspended in collagen and maintained in tissue culture.
  • After expansion (>20 passages), the urothelium was recombined with embryonic day-14 mouse bladder mesenchyme, then grafted beneath the renal capsule of immunocompromised mouse hosts.
  • Control grafts were performed with bladder mesenchyme alone, cultured bladder urothelium alone, and collagen matrix alone.
  • Staining of recombinant grafts demonstrated bladder tissue with mature urothelium and stromal differentiation.
  • Control tissues were void of bladder tissue formation.
  • We have successfully demonstrated that a chimeric bladder is formed from primary cultured bladder urothelium recombined with embryonic bladder mesenchyme.
  • This is a powerful new tool for investigating the molecular mechanisms of bladder development and disease.
  • [MeSH-major] Mesoderm / metabolism. Transplantation, Heterologous / methods. Urinary Bladder / physiology. Urothelium / cytology

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2006 Wiley-Liss, Inc.
  • (PMID = 16804891.001).
  • [ISSN] 1058-8388
  • [Journal-full-title] Developmental dynamics : an official publication of the American Association of Anatomists
  • [ISO-abbreviation] Dev. Dyn.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Membrane Glycoproteins; 0 / Uroplakin III
  •  go-up   go-down


81. Tubaro A, Palleschi G: Overactive bladder: epidemiology and social impact. Curr Opin Obstet Gynecol; 2005 Oct;17(5):507-11
MedlinePlus Health Information. consumer health - Urinary Incontinence.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Overactive bladder: epidemiology and social impact.
  • PURPOSE OF REVIEW: Overactive bladder epidemiology is a rapidly evolving field.
  • The new terminology of lower urinary tract function, introduced in 2002, modified the definitions of all four components of overactive bladder.
  • In the same year, the lack of specific information on overactive bladder prevalence was identified and consequently new studies were launched and recently published.
  • RECENT FINDINGS: Following the new terminology, overactive bladder now includes both a purely sensory disorder and a condition related to an altered bladder behaviour.
  • 'Urge' is now considered the cornerstone symptom of overactive bladder.
  • Recent epidemiological data confirm the increase in overactive bladder prevalence with age and suggest that most diet and lifestyle factors are not associated with the condition, with the exception of body mass index.
  • Among the symptoms, urge and urinary incontinence were considered to be more significantly related to patients' quality of life compared with frequency and nocturia.
  • The socioeconomic consequences of the overactive bladder syndrome were recently estimated in a large US study and a total cost of 12.6 billion US dollars was calculated.
  • SUMMARY: Specific data on overactive bladder epidemiology are now available, providing new evidence about its relevance as a clinical issue.
  • Both wet and dry overactive bladder cause a significant reduction in quality of life.
  • In our daily practice we have to consider that overactive bladder is frequently underreported as patients believe that no treatment is available and urinary incontinence is considered a natural consequence of aging.
  • [MeSH-major] Urinary Bladder Diseases / epidemiology. Urinary Incontinence / epidemiology

  • MedlinePlus Health Information. consumer health - Bladder Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16141765.001).
  • [ISSN] 1040-872X
  • [Journal-full-title] Current opinion in obstetrics & gynecology
  • [ISO-abbreviation] Curr. Opin. Obstet. Gynecol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 22
  •  go-up   go-down


82. Sudhakar PJ, Malik N, Malik A: Leiomyoma of bladder. Saudi J Kidney Dis Transpl; 2008 Mar;19(2):232-5
MedlinePlus Health Information. consumer health - Bladder Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Leiomyoma of bladder.
  • A case of leiomyoma of urinary bladder, a rare benign tumor, is presented.
  • The clinical presentation, imaging findings and management of this benign tumor are discussed.
  • [MeSH-major] Leiomyoma / radiography. Urinary Bladder Neoplasms / radiography

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18310873.001).
  • [ISSN] 1319-2442
  • [Journal-full-title] Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia
  • [ISO-abbreviation] Saudi J Kidney Dis Transpl
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Saudi Arabia
  • [Chemical-registry-number] 0 / Contrast Media
  •  go-up   go-down


83. Permpongkosol S, Nicol TL, Kavoussi LR, Jarrett TW: Percutaneous bladder cryoablation in porcine model. J Endourol; 2006 Dec;20(12):991-5
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Percutaneous bladder cryoablation in porcine model.
  • PURPOSE: To demonstrate the morphologic changes of full-thickness bladder cryoablation utilizing contemporary percutaneous technology.
  • MATERIALS AND METHODS: Cryoablation of the bladder wall was conducted in 24 pigs.
  • Single or double freeze/thaw cycles were applied, and no bladder drainage was used.
  • The bladder was evaluated for perforation, and histologic examination was undertaken to assess the extent of acute, subacute (2 weeks), or chronic (1 month) lesions.
  • Bladder perforation was not detected clinically or at autopsy.
  • CONCLUSION: Cryoablation produces reliable zones of tissue destruction without bladder perforation.
  • These preliminary data show the safety and feasibility for trials in the treatment of bladder tumors by laparoscopic, cystoscopic, or image-guided techniques.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17206889.001).
  • [ISSN] 0892-7790
  • [Journal-full-title] Journal of endourology
  • [ISO-abbreviation] J. Endourol.
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


84. Sung W, Park BD, Lee S, Chang SG: Villous adenoma of the urinary bladder. Int J Urol; 2008 Jun;15(6):551-3
MedlinePlus Health Information. consumer health - Bladder Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Villous adenoma of the urinary bladder.
  • Villous adenomas arising in the urinary tract are an uncommon occurrence.
  • They have been identified in the urachus, urethra, prostate, and throughout the bladder.
  • Villous adenomas arising in the bladder are rare tumors that have been described as isolated cases and a few case series.
  • We report a new case of a large villous adenoma arising in the bladder that was treated by transurethral resection.
  • [MeSH-major] Adenoma, Villous / diagnosis. Urinary Bladder Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18489648.001).
  • [ISSN] 1442-2042
  • [Journal-full-title] International journal of urology : official journal of the Japanese Urological Association
  • [ISO-abbreviation] Int. J. Urol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Australia
  •  go-up   go-down


85. Kohno T, Kitamura M, Akai H, Takaha M, Kawahara K, Oka T: Plasmacytoid urothelial carcinoma of the bladder. Int J Urol; 2006 Apr;13(4):485-6
MedlinePlus Health Information. consumer health - Bladder Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Plasmacytoid urothelial carcinoma of the bladder.
  • We report the first case of a pathological complete response for plasmacytoid urothelial carcinoma of the bladder.
  • [MeSH-major] Carcinoma / pathology. Urinary Bladder Neoplasms / pathology
  • [MeSH-minor] Aged. Antineoplastic Agents / therapeutic use. Biopsy. Cystectomy. Diagnosis, Differential. Fatal Outcome. Humans. Male. Neoplasm Staging. Urothelium / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16734884.001).
  • [ISSN] 0919-8172
  • [Journal-full-title] International journal of urology : official journal of the Japanese Urological Association
  • [ISO-abbreviation] Int. J. Urol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Antineoplastic Agents
  •  go-up   go-down


86. Shah A, Chandran H: Malakoplakia of bladder in childhood. Pediatr Surg Int; 2005 Feb;21(2):113-5
MedlinePlus Health Information. consumer health - Bladder Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malakoplakia of bladder in childhood.
  • We report a case of malakoplakia presenting as multiple bladder polyps in an 11-year-old boy.
  • [MeSH-major] Malacoplakia / surgery. Urinary Bladder Diseases / surgery

  • Genetic Alliance. consumer health - Malakoplakia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15635465.001).
  • [ISSN] 0179-0358
  • [Journal-full-title] Pediatric surgery international
  • [ISO-abbreviation] Pediatr. Surg. Int.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


87. Macejko AM, Viprakasit DP, Nadler RB: Cystoscope- and robot-assisted bladder diverticulectomy. J Endourol; 2008 Oct;22(10):2389-91; discussion 2391-2
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cystoscope- and robot-assisted bladder diverticulectomy.
  • BACKGROUND AND PURPOSE: Minimally invasive approaches to manage bladder diverticula have become increasingly popular; however, intracorporeal identification of bladder diverticula may be challenging.
  • PATIENTS AND METHODS: After management of bladder neck obstruction, two patients with bladder diverticula and persistent lower urinary tract symptoms underwent robot-assisted bladder diverticulectomy.
  • RESULTS: Our technique was simple to perform and facilitated identification and dissection of bladder diverticula.
  • CONCLUSIONS: Cystoscope-assisted illumination provides a straightforward method of identifying bladder diverticula during robot-assisted laparoscopic diverticulectomy.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18937603.001).
  • [ISSN] 1557-900X
  • [Journal-full-title] Journal of endourology
  • [ISO-abbreviation] J. Endourol.
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


88. MacLellan DL: Management of pediatric neurogenic bladder. Curr Opin Urol; 2009 Jul;19(4):407-11
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Management of pediatric neurogenic bladder.
  • PURPOSE OF REVIEW: To review the most current literature regarding the management of neurogenic bladder in children.
  • RECENT FINDINGS: Several recent papers have addressed the investigation and management of children with neurogenic bladder.
  • Bladder wall thickness as measured by ultrasound may identify the children with urodynamic risk factors for upper urinary tract deterioration.
  • Strategies such as maximal anticholinergic therapy, total endoscopic management, conservative management throughout puberty, and isolated bladder neck procedures to avoid bladder augmentation show promise.
  • As children with neurogenic bladder enjoy longer life spans, issues including risks of malignancy related to augmentation and transition to adult-centered care will continue to gain significance.
  • SUMMARY: Pediatric urologists continue to face many challenges in the management of children with neurogenic bladder.
  • This includes identifying predictors of upper urinary tract deterioration, finding efficacious strategies to avoid bladder augmentation, and long-term care.
  • [MeSH-major] Urinary Bladder, Neurogenic / physiopathology. Urinary Bladder, Neurogenic / therapy
  • [MeSH-minor] Adolescent. Child. Child, Preschool. Cholinergic Antagonists / therapeutic use. Humans. Treatment Outcome. Urinary Bladder / physiopathology. Urinary Bladder / surgery. Urinary Bladder / ultrasonography. Urodynamics / physiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19440150.001).
  • [ISSN] 1473-6586
  • [Journal-full-title] Current opinion in urology
  • [ISO-abbreviation] Curr Opin Urol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cholinergic Antagonists
  • [Number-of-references] 16
  •  go-up   go-down


89. Spiess PE, Czerniak B: Dual-track pathway of bladder carcinogenesis: practical implications. Arch Pathol Lab Med; 2006 Jun;130(6):844-52
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Dual-track pathway of bladder carcinogenesis: practical implications.
  • CONTEXT: The concept of a dual-track pathway in bladder carcinogenesis postulates that bladder cancer develops via 2 distinct but somewhat overlapping pathways, termed the papillary and nonpapillary.
  • Approximately 80% of bladder carcinomas consist of superficial exophytic papillary lesions that originate from urothelial hyperplasia.
  • These typically low-grade papillary tumors may recur, but they rarely invade the bladder wall or metastasize.
  • The remaining 15% to 20% of tumors represent high-grade solid nonpapillary bladder carcinoma, which arise from high-grade intraurothelial neoplasia.
  • These tumors aggressively invade the bladder wall and have a high propensity for distant metastasis.
  • OBJECTIVE: To summarize the scientific literature and provide a clinicopathologic review of the dual-track concept of bladder carcinogenesis with its important implications.
  • CONCLUSIONS: Although the characteristics of papillary and nonpapillary tumors are quite dissimilar, current evidence implies that both forms of bladder cancer start as a clinically occult clonal expansion of preneoplastic lesions that occupy large areas of the bladder mucosa.
  • [MeSH-major] Carcinoma, Squamous Cell / etiology. Carcinoma, Squamous Cell / pathology. Carcinoma, Transitional Cell / etiology. Carcinoma, Transitional Cell / pathology. Urinary Bladder Neoplasms / etiology. Urinary Bladder Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16740038.001).
  • [ISSN] 1543-2165
  • [Journal-full-title] Archives of pathology & laboratory medicine
  • [ISO-abbreviation] Arch. Pathol. Lab. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 72
  •  go-up   go-down


90. Pastor Navarro H, Martínez Ruiz J, Carrión Lopez P, Martínez Sanchíz C, Lorenzo Romero JG, Cañamares Pabolaza L, Polo Ruiz L, Pastor Guzman JM, García Blazquez E, Virseda Rodríguez JA: Tumor inside an inguinoscrotal bladder hernia. Arch Esp Urol; 2010 Jul-Aug;63(6):471-6
MedlinePlus Health Information. consumer health - Hernia.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tumor inside an inguinoscrotal bladder hernia.
  • OBJECTIVE: To describe two cases of urothelial tumors in inguinoscrotal bladder hernias and comment on the low incidence of this condition.
  • RESULTS: The clinical outcome of both patients was good at two and three years, respectively, and neither patient experienced hernia or tumor recurrence.
  • CONCLUSIONS: Inguinal bladder hernias are relatively common.
  • However, few reports of tumor in the herniated bladder have been published.
  • Treatment consists of tumor removal, hernia repair and treatment of any associated urethroprostatic condition.
  • [MeSH-major] Carcinoma / complications. Hernia / complications. Inguinal Canal. Scrotum. Urinary Bladder Diseases / complications. Urinary Bladder Neoplasms / complications

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • MedlinePlus Health Information. consumer health - Bladder Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20820087.001).
  • [ISSN] 1576-8260
  • [Journal-full-title] Archivos españoles de urología
  • [ISO-abbreviation] Arch. Esp. Urol.
  • [Language] eng; spa
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


91. Halachmi S: The molecular pathways behind bladder stretch injury. J Pediatr Urol; 2009 Feb;5(1):13-6
MedlinePlus Health Information. consumer health - Urine and Urination.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The molecular pathways behind bladder stretch injury.
  • Stretch injury is a non-reversible process that changes the cellular and extracellular characteristics of the bladder wall, leading to bladder dysfunction.
  • Posterior urethral valve and neurogenic bladder are examples of disorders that may lead to stretch injury.
  • The current literature is reviewed in this paper, with the aim of giving some insight into the molecular and genetic pathways of bladder stretch injury.
  • [MeSH-major] Extracellular Matrix / metabolism. Muscle Spindles. Muscle, Smooth / metabolism. Protein Kinases / metabolism. Urinary Bladder. Urination Disorders

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18793873.001).
  • [ISSN] 1873-4898
  • [Journal-full-title] Journal of pediatric urology
  • [ISO-abbreviation] J Pediatr Urol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / RNA, Messenger; EC 2.7.- / Protein Kinases
  • [Number-of-references] 23
  •  go-up   go-down


92. Barocas DA, Clark PE: Bladder cancer. Curr Opin Oncol; 2008 May;20(3):307-14
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bladder cancer.
  • PURPOSE OF REVIEW: To review the diagnosis and management of bladder cancer with an emphasis on studies and developments over the past year.
  • RECENT FINDINGS: Cystoscopy remains the mainstay in the detection and surveillance of bladder cancer, though fluorescent light may enhance detection.
  • Efforts continue in the development of urinary bladder cancer markers.
  • Superficial bladder cancer is still managed with transurethral resection and perioperative instillation of chemotherapy for most patients.
  • Research on the use of laparoscopy, the effect on patients' health-related quality of life, and the potential role for bladder preservation strategies is ongoing.
  • SUMMARY: We are encouraged by the progress in bladder cancer diagnosis and management, but considerably more work needs to be done to improve on the lives of our patients with this disease.
  • [MeSH-major] Urinary Bladder Neoplasms / diagnosis
  • [MeSH-minor] Antineoplastic Agents / therapeutic use. Biomarkers, Tumor. Chemotherapy, Adjuvant. Cystectomy. Disease Progression. Humans. Lymph Node Excision. Prognosis

  • Genetic Alliance. consumer health - Bladder cancer.
  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18391631.001).
  • [ISSN] 1531-703X
  • [Journal-full-title] Current opinion in oncology
  • [ISO-abbreviation] Curr Opin Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Biomarkers, Tumor
  • [Number-of-references] 119
  •  go-up   go-down


93. Andersson KE: Pharmacotherapy of the overactive bladder. Discov Med; 2009 Oct;8(42):118-24
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pharmacotherapy of the overactive bladder.
  • Lower urinary tract symptoms (LUTS), the overactive bladder syndrome (OAB), and detrusor overactivity (DO) are all conditions that can have major effects on quality of life and social functioning.
  • The recognition of the functional contribution of the urothelium, the spontaneous myocyte activity during bladder filling, and the diversity of nerve transmitters involved has sparked interest in both peripheral and central modulation of LUTS/OAB/DO pathophysiology.
  • [MeSH-major] Adrenergic Agonists / therapeutic use. Muscarinic Antagonists / therapeutic use. Urinary Bladder, Overactive / drug therapy

  • MedlinePlus Health Information. consumer health - Overactive Bladder.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19833057.001).
  • [ISSN] 1944-7930
  • [Journal-full-title] Discovery medicine
  • [ISO-abbreviation] Discov Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Adrenergic Agonists; 0 / Drug Combinations; 0 / Muscarinic Antagonists; EC 3.1.4.35 / 3',5'-Cyclic-GMP Phosphodiesterases
  •  go-up   go-down


94. Chu FM, Dmochowski R: Pathophysiology of overactive bladder. Am J Med; 2006 Mar;119(3 Suppl 1):3-8
MedlinePlus Health Information. consumer health - Urinary Incontinence.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pathophysiology of overactive bladder.
  • Overactive bladder (OAB) is a complex of symptoms frequently encountered in the primary care setting.
  • Impediments to optimal management of OAB include inaccurate perceptions on the part of patients and primary care providers, e.g., that the symptoms of OAB represent a natural progression of aging and are beyond the scope of treatment or that diagnosis and treatment are specialist concerns.
  • This article reviews normal bladder function and then explores pathophysiologic changes that likely cause the symptoms of OAB.
  • [MeSH-major] Urinary Incontinence / physiopathology
  • [MeSH-minor] Aging / physiology. Humans. Urinary Bladder / physiology. Urinary Tract / anatomy & histology. Urodynamics

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16483862.001).
  • [ISSN] 1555-7162
  • [Journal-full-title] The American journal of medicine
  • [ISO-abbreviation] Am. J. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 33
  •  go-up   go-down


95. Gwynn ES, Clark PE: Bladder cancer. Curr Opin Oncol; 2006 May;18(3):277-83
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bladder cancer.
  • PURPOSE OF REVIEW: This article will review the diagnosis and management of bladder cancer at each stage, from superficial to metastatic disease with an emphasis on recent developments over the last year.
  • Areas of research include the optimal role for bladder preservation therapy, a growing experience in centers with laparoscopy, the effect of urinary diversion on quality of life, and the optimal standard for pelvic lymphadenectomy at surgery.
  • The role of combination chemotherapy for advanced bladder cancer continues to evolve.
  • SUMMARY: The detection of bladder cancer continues to rely on direct visualization with cystoscopy.
  • Efforts are underway to improve the utility of urinary markers and cystoscopy through fluorescence endoscopy.
  • The management of superficial bladder cancer is based on transurethral resection of the tumor with perioperative intravesical instillation of chemotherapy strongly suggested for most patients.
  • Risk stratifying patients with high-risk superficial bladder cancer remain a challenge and area of future research.
  • [MeSH-major] Carcinoma, Transitional Cell. Urinary Bladder Neoplasms
  • [MeSH-minor] Administration, Intravesical. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. BCG Vaccine / administration & dosage. BCG Vaccine / therapeutic use. Carcinoma in Situ / therapy. Combined Modality Therapy. Cystectomy. Disease Management. Humans. Immunotherapy. Lymph Node Excision. Neoadjuvant Therapy. Neoplasm Invasiveness. Neoplasm Metastasis

  • Genetic Alliance. consumer health - Bladder cancer.
  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16552241.001).
  • [ISSN] 1531-703X
  • [Journal-full-title] Current opinion in oncology
  • [ISO-abbreviation] Curr Opin Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / BCG Vaccine
  • [Number-of-references] 73
  •  go-up   go-down


96. Roosen A, Apostolidis A, Elneil S, Khan S, Panicker J, Brandner S, Fowler CJ, Kessler TM: Cadherin-11 up-regulation in overactive bladder suburothelial myofibroblasts. J Urol; 2009 Jul;182(1):190-5
Faculty of 1000. commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine. (subscription/membership/fee required).

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cadherin-11 up-regulation in overactive bladder suburothelial myofibroblasts.
  • PURPOSE: We investigated whether the adherens junction proteins cadherin-11 and beta-catenin can be immunohistochemically visualized in the human bladder using commercially available antibodies and, if so, whether there are differences between patients with overactive bladder and refractory detrusor overactivity, and controls without lower urinary tract symptoms.
  • MATERIALS AND METHODS: In a prospective, nonrandomized single center study 32 patients with overactive bladder and refractory detrusor overactivity, and 8 controls without lower urinary tract symptoms underwent cystoscopic bladder biopsy.
  • The primary outcome was cadherin-11 and beta-catenin expression in the human bladder using commercially available antibodies.
  • The secondary outcome was differences in cadherin-11 and beta-catenin in patients with overactive bladder and refractory detrusor overactivity, and controls.
  • Significant 2-fold up-regulation of cadherin-11 was found in the suburothelium of patients with overactive bladder compared with that in controls (p = 0.018), whereas beta-catenin was similar in the groups (p = 0.6).
  • In the detrusor cadherin-11 and beta-catenin expression was comparable in patients with overactive bladder and controls (each p = 0.5).
  • No difference was observed in cadherin-11 and beta-catenin in patients with overactive bladder with idiopathic vs neurogenic detrusor overactivity in the suburothelium and the detrusor (p >0.3 and >0.2, respectively).
  • CONCLUSIONS: Using commercially available antibodies cadherin-11 and beta-catenin expression in human bladder suburothelial myofibroblasts and detrusor smooth muscle cells was noted.
  • Cadherin-11 up-regulation in suburothelial myofibroblasts in patients with overactive bladder may be significant in overactive bladder pathogenesis.
  • [MeSH-major] Cadherins / metabolism. Muscle, Smooth / physiopathology. Urinary Bladder, Overactive / metabolism. Urinary Bladder, Overactive / pathology

  • MedlinePlus Health Information. consumer health - Overactive Bladder.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19450843.001).
  • [ISSN] 1527-3792
  • [Journal-full-title] The Journal of urology
  • [ISO-abbreviation] J. Urol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cadherins; 156621-71-5 / osteoblast cadherin
  •  go-up   go-down


97. Karim T, Topno M, Sharma V, Picardo R, Hastir A: Bladder injuries frequently missed in polytrauma patients. Open Access J Urol; 2010;2:63-5

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bladder injuries frequently missed in polytrauma patients.
  • Bladder injuries are very common in patients who have had road traffic accidents.
  • The method of diagnosis and management of such injuries is well established and accepted.
  • However, trauma to the bladder can be associated with other life-threatening injuries which are frequently missed, and often diagnosed during laparotomy for other reasons.
  • The aim of this study was to diagnose bladder injury in polytrauma patients as early as possible, taking into consideration the fact that these patients are hemodynamically unstable and require rapid evaluation and management.
  • In order to achieve our objective, we used bedside sonography with retrograde instillation of normal saline to diagnose bladder injury in addition to use of the conventional retrograde cystogram.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 24198615.001).
  • [ISSN] 1179-1551
  • [Journal-full-title] Open access journal of urology
  • [ISO-abbreviation] Open Access J Urol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] New Zealand
  • [Other-IDs] NLM/ PMC3818878
  • [Keywords] NOTNLM ; bladder injury / bladder rupture / retrograde cystogram
  •  go-up   go-down


98. Crallan RA, Georgopoulos NT, Southgate J: Experimental models of human bladder carcinogenesis. Carcinogenesis; 2006 Mar;27(3):374-81
Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Experimental models of human bladder carcinogenesis.
  • Bladder cancer is the fifth most common cancer in the UK, yet human bladder carcinogenesis remains poorly understood and the response of bladder tumours to radio- and chemo-therapy is unpredictable.
  • The aims of this article are to review human bladder carcinogenesis and appraise the different in vitro and in vivo approaches that have been developed to study the process.
  • The review considers how in vitro models based on normal human urothelial (NHU) cells can be applied to human bladder cancer research.
  • We conclude that recent advances in NHU cell culture offer novel approaches for defining urothelial tissue-specific responses to genotoxic and non-genotoxic carcinogens and elucidating the role of specific genes involved in the mechanisms of bladder carcinogenesis and malignant progression.
  • [MeSH-major] Cell Transformation, Neoplastic. Disease Models, Animal. Urinary Bladder Neoplasms / physiopathology. Urothelium / cytology

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16287878.001).
  • [ISSN] 0143-3334
  • [Journal-full-title] Carcinogenesis
  • [ISO-abbreviation] Carcinogenesis
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Carcinogens
  • [Number-of-references] 137
  •  go-up   go-down


99. Tomita SS, McTiernan TL, Ginsburg HB: An unusual form of duplicate bladder exstrophy. J Pediatr Surg; 2010 Apr;45(4):834-6
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An unusual form of duplicate bladder exstrophy.
  • Duplicate bladder exstrophy is a rare variant of the exstrophy/epispadic lesions in which an external patch of exstrophic bladder presents in addition to a closed bladder in a more normal anatomical position, diastasis of the pubis and rectus muscles, and often a form of epispadias.
  • We describe an anomaly of this variant with a fistula to the closed bladder.
  • [MeSH-major] Bladder Exstrophy. Urinary Bladder / abnormalities. Urinary Bladder Fistula
  • [MeSH-minor] Epispadias / diagnosis. Epispadias / surgery. Humans. Infant, Newborn. Male

  • Genetic Alliance. consumer health - Exstrophy of the Bladder.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20385297.001).
  • [ISSN] 1531-5037
  • [Journal-full-title] Journal of pediatric surgery
  • [ISO-abbreviation] J. Pediatr. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


100. Purohit RS, Blaivas JG, Saleem KL, Sandhu J, Weiss JP, Reddy B, Sidhu RK: The pathophysiology of large capacity bladder. J Urol; 2008 Mar;179(3):1006-11
MedlinePlus Health Information. consumer health - Bladder Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The pathophysiology of large capacity bladder.
  • PURPOSE: We describe the pathophysiology, differential diagnosis and urodynamic findings in patients with a large capacity bladder.
  • MATERIALS AND METHODS: This was a retrospective, observational study of 100 consecutive patients with voiding dysfunction and a cystometric bladder capacity of greater than 700 ml.
  • Clinical data, cystometric bladder capacity and other urodynamic findings were evaluated.
  • Bladder outlet obstruction and impaired detrusor contractility were defined by the Schaefer nomogram in men and the Blaivas-Groutz nomogram in women.
  • RESULTS: A total of 56 men and 44 women 36 to 97 years old (median age 75, mean 71.2) with a bladder capacity of 700 to 5,013 ml (median 931, mean 1,091) were studied.
  • The primary pathophysiological diagnoses were bladder outlet obstruction in 48% of cases, impaired detrusor contractility in 11%, absent detrusor contractility in 24% and normal detrusor pressure/uroflow study in 17%.
  • Bladder outlet obstruction was attributable to anatomical obstruction in 34% of patients, acquired voiding dysfunction in 11% and detrusor-external sphincter dyssynergia in 3%.
  • Associated diagnoses in men included benign prostatic enlargement in 52% and neurological disease in 14%, and in women they were pelvic organ prolapse in 27%, stress incontinence in 18% and neurological disorders in 9%.
  • CONCLUSIONS: The etiology of large capacity bladder is multifactorial and often a potentially remediable underlying condition exists.
  • A large capacity bladder may be accompanied by bladder outlet obstruction, impaired or absent detrusor contractions, or normal detrusor pressure/uroflow studies.
  • When detrusor contractions are present, they usually occur only at large bladder volumes.
  • Therefore, it is important during cystometry to fill the bladder until capacity is achieved.
  • [MeSH-major] Urinary Bladder / physiopathology. Urinary Bladder Diseases / physiopathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18206947.001).
  • [ISSN] 1527-3792
  • [Journal-full-title] The Journal of urology
  • [ISO-abbreviation] J. Urol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down






Advertisement